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     Translating mRNA sequences into functional proteins is a fundamental process 
necessary for the viability of organisms throughout all kingdoms of life.  The 
ribosome carries out this process with a delicate balance between speed and accuracy.  
Although kinetic and biochemical studies along with high resolution crystal structures 
have provided much information about the ribosome, many of the underlying 
mechanisms of ribosome function are still poorly understood.  This work seeks to 
understand how ribosome structure and function are affected by changes in rRNA as 
caused by two very different mechanisms.  mof6-1, originally isolated as a recessive 
mutation which promoted increased efficiencies of programmed -1 ribosomal 
frameshifting, was found to be an allele of RPD3 which encodes a histone deacetylase 
that is involved in transcriptional activation and silencing.  This mutant demonstrated 
a delay in ribosomal RNA (rRNA) processing leading to changes in reading frame 
  
maintenance and ribosomal A-site specific defects.  To understand the role of cis-
acting changes to rRNA, yeast strains deficient in rRNA modifications in the peptidyl 
transferase center of the ribosome were monitored for changes in ribosome structure 
and translational fidelity.  Analyses revealed mutant phenotypes including sensitivity 
to translational inhibitors; changes in reading frame maintenance, nonsense 
suppression and aa-tRNA selection; and increased rates of A-site tRNA binding to the 
mutant ribosome.  One mutant in particular, spb1DA/snr52Δ, promoted increased 
rates of programmed -1 ribosomal frameshifting, increased rates of near cognate 
tRNA selection and A-site tRNA binding.  Structural analysis of spb1DA/snr52Δ 
revealed changes consistent with a more accessible ribosomal A-site.  These results 
suggest that rRNA nucleotide modifications produce small but distinct changes in 
ribosome structure and function contributing to overall translational fidelity. 
 
     Taken together, these data suggest that rRNA, a main component of the ribosome, 
contributes directly to translational fidelity.  Defects in rRNA caused by changes in 
both its processing and modification can cause changes in reading frame 
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Chapter 1: An Ingress 
 
Introduction 
     Translation, the decoding of information contained within messenger RNA 
(mRNA) into its corresponding protein, is a fundamental process carried out in all 
kingdoms of life and is crucial for cell growth and proliferation.  This process is 
mediated primarily by the ribosome in conjunction with associated protein factors.  In 
all growing cells, a vast amount of energy and resources is dedicated to the 
biosynthesis of ribosomes.  It has been estimated that a growing cell manufactures as 
many as 2000 ribosomes per minute (Warner, 1999).  In the face of such intense 
energetic demands, it is essential that the many steps involved in ribosome biogenesis 
be efficient and well coordinated.  The ribosome is made up of two subunits, each of 
which consists of ribosomal RNA (rRNA) and as many as 70 to 100 ribosomal 
proteins.  In eukaryotes, ribosome biogenesis begins in the nucleolus where a large 
precursor rRNA is synthesized by RNA polymerase I (Pol I).  This precursor rRNA 
undergoes a series of cleavage events, nucleotide modifications and folding steps 
resulting in mature rRNA species.  In the yeast Saccharomyces cerevisiae, a 35S 
rRNA precursor is processed into three mature rRNA species: 18S, 5.8S and 25S 
(Figure 1.1) (Decatur and Fournier, 2003).  An additional rRNA component required 
for ribosome formation is 5S rRNA, which is independently transcribed by RNA 












addition to mature rRNAs, production and assembly of the mature 60S (large) and 
40S (small) subunits that comprise a complete 80S yeast ribosome requires 
approximately 80 ribosomal proteins and greater that 150 accessory proteins and 
small RNAs.  In yeast, this process is completed in the cytoplasm with the final 




     One vital component of ribosome biogenesis involves pre-rRNA nucleotide 
modification.  Such rRNA modifications are found in all known ribosomes, although 
their location and abundance vary among phylogenetic kingdoms (Rozenski et al., 
1999).  There are over 200 modified nucleotides in human rRNA, over 100 in the 
yeast S. cerevisiae, and close to 40 modified nucleotides found in the eubacteria E. 
coli rRNA.  Three general nucleotide modifications occur in rRNA: 1) 
pseudouridylation – the conversion of uridine to pseudouridine (Ψ), 2) methylation- 
addition of a methyl group to the ribose 2’hydroxyls (Nm), and 3) other 
modifications- primarily base methylation at various positions.  The most abundant 
modifications are pseudouridylation and 2’-O-methylation.    In eukaryotes, two 
classes of small nucleolar RNA-protein complexes (snoRNPs) labeled H/ACA and 
C/D type snoRNPs mediate each of these modification reactions1.  They are classified 
as such because they each contain a small nucloelar RNA (snoRNA) harboring 
                                               
1 In eubacteria, only specific protein enzymes are required to carry out nucleotide modification without 
RNA guides.  In archaea, small guide RNAs, called sRNAs, form snRNPs and are involved in site-
specific RNA modification in an evolutionarily related process to eukaryotes.    Eukaryotic 




conserved H and ACA or C and D sequence motifs (often called ‘boxes’) (Balakin et 
al., 1996a). The snoRNPs of both classes consist of a snoRNA, which serves as a 
guide sequence, and at least four specific proteins.  During the modification reaction, 
the snoRNA provides site specificity through base pairing with the target RNA 
allowing the enzymatic protein to catalyze the modification of a specific nucleotide.  
The residue ultimately modified resides within the target RNA sequence that is base 
paired to the guide snoRNA and at a specific location relative to the H/ACA or C/D 
boxes.  Pseudouridylation and 2’-O-methylation reactions are performed by H/ACA 
and C/D box snoRNPs respectively.     
 
     SnoRNA molecules are short, usually ranging between 80-400 nucleotides (nt)2.  
They exist in a wide range of eukaryotes3 with the vast majority of research 
performed in yeast and mammalian systems.  Most H/ACA and C/D box snoRNAs 
are transcribed by RNA polymerase II (Pol II).  Their genomic locations vary among 
eukaryotes.  Most mammalian snoRNAs are located in the introns of protein-coding 
genes, while most yeast snoRNAs are processed from polycisronic transcripts or are 
transcribed from independent genes.  Both intronic and polycistronic transcriptional 
units yield pre-snoRNAs which require processing to mature.  Intronic snoRNAs are 
processed in two ways.  The primary pathway involves debranching the spliced lariat 
followed by exonucleolytic digestion of extraneous sequence.  The second pathway 
operates independent of splicing, where the snoRNAs are excised from the introns 
through endonucleotytic cleavage followed by trimming.  SnoRNAs encoded by 
                                               
2 Some exceptions are snR30 consisting of 608 nt and snR59 with 78nt. 
3 SnoRNAs have been found in eukaryotes including but not limited to humans, mice, Xenopus, D. 




polycistronic transcription units undergo endonucleolytic cleavage followed 
exonucleolytic processing to remove excess nucleotides.   
 
     All guide H/ACA snoRNAs share a hairpin-hinge-hairpin-tail secondary structure 
with the conserved sequence ANANNA (H box) in the hinge region and the ACA 
motif exactly three nucleotides from the 3’end in the tail structure (Figure 1.2b).  
Guide H/ACA snoRNAs facilitate pseudouridylation through complementary base 
pair interactions with a 6-20 nucleotide stretch of the target rRNA encompassing the 
targeted U residue.  This interaction occurs in such a way as to leave the targeted U 
residue unpaired in a hairpin bulge creating a ‘pseudouridylation pocket’ thereby 
making it available to the pseudouridine synthase (Ni et al., 1997; Ganot et al., 
1997a).  Formation of Ψ is known to require the breakage of the N1-glycosyl bond, 
rotation of the uracil ring by 180° followed by formation of the C5-glycosyl bond 
(Chu et al., 1976).  Guide H/ACA RNAs associate with at least four proteins to form 
a functional snoRNP complex.  The snoRNA-directed pseudouridylation is carried 
out by yeast Cbf5fp (mammalian/human Nap57p/dyskerin) (Lafontaine et al., 1998; 
Zebarjadian et al., 1999).  The other guide H/ACA snoRNA associated proteins in 
yeast include Gar1p, Nhp2p, and Nop10p (Balakin et al., 1996b; Ganot et al., 1997b; 
Henras et al., 1998; Watkins et al., 1998).   
 
     The methylation C/D snoRNAs contain the conserved C (consensus sequence 
RUGAUGA, where R stands for any purine) and D (consensus CUGA) boxes near 




brought together by a short base pair interaction between the termini.  C/D snoRNAs 
also contain second set of motifs that resemble the boxes C/D called C’ and D’ boxes, 
which are located more internal to the RNA (Kiss-Laszlo et al., 1998).  These 
snoRNAs direct methylation through base-pairing the target RNA with a 10-21 nt 
region of complementarity located immediately upstream of the box D (or D’) region 
of the snoRNA (Cavaille and Bachellerie, 1998).  The nucleotide targeted for 
methylation is located within the base-paired region 5 bp upstream of the D (or D’ 
box) of the snoRNA.  Nm formation involves a methytransfer reaction between S-
adenosyl methionine and the target RNA.  Box C/D snoRNAs are complexed with at 
least three proteins to form a mature C/D snoRNP.  C/D snoRNA guided 2’-0-
methylation of rRNA is performed by yeast Nop1p (human fibrillarin) 
methytransferase (Schimmang et al., 1989).  Other associated proteins in yeast (and 
humans) include Nop56p (hNop56p), Nop58p (hNop58p) and Snu13p (15.5 kDa) 
(Gautier et al., 1997; Lafontaine and Tollervey, 1999; Lafontaine and Tollervey, 
2000).     
 
     It is important to note that nucleotide modification is not limited to rRNA.  Other 
small stable RNAs such as splicing snRNAs (small nuclear RNAs) and tRNAs are 
also modified.  U2 snRNA contains a Ψ residue highly conserved among eukaryotes 
(Zhao and Yu, 2004), that greatly facilitates splicing (Valadkhan and Manley, 2003) 
by establishing a favorable branch site conformation.  Most knowledge obtained 
about modified nucleotides, however, has originated from the extensive studies on 








throughout the molecule on the sugar or the base.  These modifications in the core of 
the molecule function to facilitate proper folding and increase stability either through 
direct interaction or as a mediator for magnesium ion binding (Kowalak et al., 1994; 
Agris, 1996; Durant et al., 2005).  Modifications in the anti-codon loop of the tRNA 
can contribute to the specificity and stability of the codon:anti-codon interactions 
between the tRNA and mRNA within the ribosome (Sundaram et al., 2000).  tRNA 





     Ribosomes, along with the rest of the translation machinery, have evolved to 
promote efficient and accurate translation, a delicate balance between speed and 
fidelity.  Translation can be divided into three stages: initiation, elongation and 
termination.  During initiation, ribosomes are loaded onto the mRNA, elongation 
factors are added and exchanged while the start codon is located and outfitted with a 
Met-tRNAiMet (methionyl initiator transfer RNA) in the ribosomal peptidyl (P) site.  
Elongation involves docking of aminoacyl-tRNAs (aa-tRNA) into the acceptor (A) 
site of the ribosome.  This is followed by decoding, whereby the cognate aa-tRNA is 
recognized and accommodated into the A-site.  The third step is peptidyl transfer, the 
ribosome catalyzed formation of a peptide bond between the amino acids located at 








ribosome to encounter the next codon in its A- site so the elongation cycle can begin 
again (Figure 1.3).  This iterative process continues until the ribosome encounters a 




     In eukaryotes4, translation initiation begins with formation of the eIF2/GTP/Met-
tRNAi ternary complex (Figure 1.4).  This complex binds ribosomal 40S SSU (small 
subunit) along with eIF1, eIF1A, eIF5 and eIF3 to create the 43S pre-initiation 
complex.  The eIF4F complex recruits the 43S pre-initiation complex to the mRNA.  
The components of the eIF4F complex interact with the 7-methylguanosine (m7G) 
cap located at the 5’end of the mRNA molecule and with poly A binding protein 
(PABP) bound to the 3’ end poly A tail thereby circularizing the message.  The 
initiation complex scans the message in a 5’ to 3’ direction in search of the correct 
initiation (AUG) codon, which is located in a favorable sequence context.  Initiation 
codon recognition is thought to involve base-pair formation with the initiator tRNA 
resulting in GTP hydrolysis by eIF2.  This triggers release of eIF2-GDP and the other 
initiation factors which facilitates ribosomal 60S LSU binding to the 40S/Met-
tRNAi/mRNA complex.  The end result of translation initiation yields 80S ribosomes 
bound to the mRNA with the Met-tRNAi base-paired to the AUG codon positioned in 
the P-site of the ribosome.
                                               
4 Translation initiation differs between prokaryotes and eukaryotes in execution but not outcome.  
Differences in prokaryotes include absence of  mRNA 5’cap and start codon recognition involving a 
Shine-delgarno sequence rather than ribosome scanning.  For review see (Kozak, 1999).  Eukaryotic 











Translation can also be initiated through 5' cap-independent mechanisms.  Such 
initiation is mediated by ribosomes binding to highly structured regions in the 5' NTR 
(non-translated regions) of RNAs called IRESs (internal ribosome entry site).  IRES 
elements are present in viral mRNAs and vary in size, structure and in the trans-
acting factors required for efficient translation (Pisarev et al., 2005).  Some 
picornavirus IRESs, like encephalomycarditis virus (EMCV), requires initiation 
factors eIFs 2, 3 and 4 for 40S subunit recruitment.  In contrast, the hepatitis C virus 
(HCV) IRES can recruit 40S ribosomal subunits near the initiation codon without any 
initiation factors, but requires the initiation ternary complex for correct positioning 
(Pestova et al., 1998).  Remarkably, the cricket paralysis virus (CrPV) IRES mediates 
initiation in a factor independent manner.  The IRES can correctly assemble and 
position 80S ribosomes and to begin translation in the absence of any eIFs or the 
ternary complex (Wilson et al., 2000). 
 
     Mammalian cellular mRNAs have been identified which also contain naturally 
occurring IRES elements (Hellen and Sarnow, 2001).  The structures, trans-acting 
elements, and functional mechanisms for cellular mRNA IRESs are largely unknown. 
While viral IRES elements often contain one highly ordered structural element which 
is essential for IRES activity, some cellular mRNA IRES elements identified so far 
contain several noncontiguous elements that each have individual IRES activity.  
IRES containing mRNAs encode growth factors, transcription and translation factors, 




IRES elements have been identified that are cell cycle and apoptosis regulated 
(Pyronnet et al., 2000; Stoneley et al., 2000; Hellen and Sarnow, 2001). 
 
Elongation 
     Unlike initiation, translation elongation is highly conserved between prokaryotes 
and eukaryotes5.  Translation elongation consists of three steps: aa-tRNA 
accommodation, peptidyl transfer, and translocation.  These steps can be represented 
as tRNA passage through the ribosome (hybrid-states model; Figure 1.5) (Moazed 
and Noller, 1989; Noller et al., 2002) and subdivided into 7 distinct kinetic stages 
(Figure 1.6).  Elongation begins with delivery of an aa-tRNA to a waiting ribosome, 
which contains a peptidyl-tRNA in the P-site and an empty A-site.  The aa-tRNA is 
delivered in a ternary complex consisting of elongation factor Tu (EF-Tu) bound to 
GTP6.  This initial binding is rapid and the aa-tRNA is positioned in the A/T hybrid 
state on the ribosome such that the aa-tRNA anti-codon end is located in the decoding 
center of the ribosome while its 3' acceptor end has not yet been accommodated into 
the ribosome and does not interact with it (Figures 1.5 and 1.7).  Subsequently, 
codon:anti-codon base-pairing occurs stabilizing interactions between the mRNA and 
aa-tRNA (Pape et al., 1999).  Correct codon:anti-codon interaction is monitored 
through a complex series of interactions and conformational changes involving the 
16S RNA, aa-tRNA and the LSU (Gabashvili et al., 1999; Ogle et al., 2001).  Correct 
                                               
5 Since most kinetic, biochemical and structural experiments were performed in E. coli, its 
nomenclature is used unless otherwise noted.  










interactions and conformational changes are transduced to EF-Tu promoting rapid 
GTP hydrolysis (Rodnina et al., 1995; Gromadski and Rodnina, 2004).  EF-Tu:GDP 
adopts a different conformation which is unfavorable to ribosome binding and 
quickly dissociates (Nissen et al., 1995; Pape et al., 1998).  EF-Tu release allows the 
3'-CCA end of the aa-tRNA to enter the LSU in the A/A site thereby finalizing 
accommodation (Figures 1.5 and 1.7).   
 
     aa-tRNA discrimination takes place at two distinct stages of the translation 
elongation cycle described above (Figure 1.6) (Ogle and Ramakrishnan, 2005).  
Initial selection takes place prior to GTP hydrolysis.  During this step, cognate and 
near cognate codon:anti-codon interactions are stabilized by the codon recognition 
step and proceed to GTP hydrolysis, whereas non-cognate tRNAs, having no 
significant codon:anti-codon interactions, promote a severely decreased rate of 
GTPase activation (providing a ~650 fold selection for cognate vs. non-cognate aa-
tRNA (Gromadski and Rodnina, 2004)) and dissociate from the ribosome (Yarus et 
al., 2003).  Thus, correct codon:anti-codon interactions serve to slow dissociation of 
the cognate tRNA from the ribosome and increase the rate of GTP activation 
(Rodnina et al., 2005).  The majority of non-cognate tRNAs are rejected during the 
initial selection step.  The proofreading step takes place after GTPase hydrolysis but 
prior to accommodation.  Most of the discrimination between cognate and near 
cognate tRNAs occurs at this step.  Any near-cognate tRNAs that have made it 








(Pape et al., 1999; Rodnina et al., 2005).  Cognate tRNAs bind more stably and have 
increased rates of accommodation while near cognate tRNAs dissociate more readily 
and have much reduced rates of accommodation.   
 
     A computer simulation has been performed which shows the path of the aa-tRNA 
as it accommodates into the ribosomal LSU (Figure 1.7a) (Sanbonmatsu et al., 2005).  
The simulation shows the aa-tRNA 3' end slips along helix 89 (h89) and h90 and then 
encounters two "gates" which cause the aa-tRNA to pause as it accommodates into 
the ribosome (Figure 1.7b).  The first gate consists of two nucleotides: U2860 of h89 
(E.coli U2492) and h92 A-loop residue C2924 (E. coli C2556).  The second gate, 
which immediately follows the first, is formed by h90 nucleotide U2941 (E. coli 
C2573).  Therefore, altering the local conformation of the ribosome or the incoming 
aa-tRNA could result in changes in accommodation and suggest a means for detecting 
near- and non- cognate aa-tRNAs in the accommodation proofreading step.  It should 
be noted that helices of the LSU rRNA involved in the accommodation of the aa-
tRNA 3'-CCA end through the ribosome (helices 89, 90 and 92) contain several 
modified nucleotides.  
 
     Peptidyl transfer occurs after accommodation and involves the transfer of the 
growing peptide chain situated on the 3' end of the peptidyl-tRNA onto the amino 
acid located on the 3'end of the aa-tRNA.  This reaction is extremely fast and is 
mediated only by the 23S rRNA7 as no cofactors, ribosomal proteins or metal ions 
come into contact with the site of peptidyl transfer 
                                               








(Nissen et al., 2000; Steitz and Moore, 2003).  Despite many rapid advances in the 
biochemical and crystallographic studies of peptidyl transfer, the exact nature of the 
reaction is unknown.  A few models have been suggested including acid-base 
catalysis (Muth et al., 2000), substrate assisted (Weinger et al., 2004), and an induced 
fit mechanism (Schmeing et al., 2005b).  The induced fit mechanism postulates that, 
upon accommodation, conformational changes in the peptidyl transferase center 
(PTC) in the ribosomal LSU serve to position the peptidyl-tRNA and its peptide chain 
in such a way as to facilitate spontaneous nucleophilic attack of the carbonyl bond 
between the peptidyl-tRNA and its peptide chain by the amino group of the aa-tRNA 
amino acid.  After peptidyl transfer takes place, it is proposed that the P- and A-site 
tRNAs adopt the P/E and A/P hybrid states in the ribosome respectively (Figure 1.5).  
The now empty 3'-end of the P-site tRNA moves into the E site of the ribosome while 
its anti-codon end is still in the P-site.  Simultaneously, the 3'-end of the A-site tRNA, 
which now carries the growing peptide chain, is located in the P-site while its anti-
codon end still resides in the A-site.  It should be noted that while some evidence for 
these intermediates has been found, the true state of the tRNA within the ribosome is 
understandably elusive and thus remains uncertain (Blanchard et al., 2004; Sharma et 
al., 2004). 
 
     Translocation involves the movement of the tRNA:mRNA complex relative to the 
ribosome by three nucleotides causing the deacylated P/E site tRNA to move entirely 
into the E-site, the A/P tRNA carrying the peptide chain to move entirely into the P-




previously 3' adjacent on the mRNA (Figure 1.5).  EF-G:GTP8 binds the ribosome 
and mediates GTP hydrolysis which is required for efficient translocation.  The 
precise mechanism of translocation is unknown.  Experiments show that both the 
large and small ribosomal subunits undergo conformational changes during 
translocation (Wilson and Noller, 1998; Gabashvili et al., 1999; Agrawal et al., 1999).  
Cryo-EM studies have revealed ratchet-like motion of the SSU relative to the LSU 
during translocation (Frank and Agrawal, 2000; Spahn et al., 2004). 
 
Termination 
    Translation elongation continues codon after codon until a termination codon is 
encountered in the ribosomal A-site.  The three natural nonsense or stop codons are 
UAA, UAG, and UGA.  In eukaryotes9, all stop codons are decoded by the class 1 
eukaryotic release factor eRF1 with help from the class 2 release factor eRF3 and 
GTP.  This triggers the release of the polypeptide chain through the hydrolysis of the 
ester bond that connects it to the peptidyl-tRNA.  It is then thought that eRF3 
mediated GTP hydrolysis occurs releasing the termination factors from the ribosome 
(Figure 1.8).   
 
     The mechanism of elongation termination is not known.  X-ray crystallographic 
studies revealed similarities in shape between class 1 release factors and the ternary 
complex suggests termination may begin in a similar way to accommodation, 
however, the mechanism of stop codon recognition is not yet completely understood 
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(Ito et al., 1996; Song et al., 2000; Chavatte et al., 2002).  In sharp contrast to 
translation elongation, ester bond hydrolysis requires entry of a water molecule into 
the PTC of the ribosome.  It has been proposed that eRF1 serves to coordinate the 
water molecule for ester bond hydrolysis (Song et al., 2000) or that conformational 
changes upon eRF1 binding would both allow water entry into the PTC and make the 





     Translating ribosomes normally remain in a single reading frame for the duration 
of polypeptide chain elongation.  Occasionally, however, ribosomes are directed by 
cis-acting mRNA signals to abandon the standard decoding rules of translation.  This 
“recoding” can result from phenomena such as bypassing (hopping over long 
stretches of mRNA), programmed stop codon read-through/redefinition, and 
programmed ribosomal frameshifting (Baranov et al., 2002; Namy et al., 2004).  
These recoding events, or "programmed mistakes", can be exploited as powerful tools 
for elucidating mechanisms influencing translational fidelity.      
 
Programmed Ribosomal Frameshifting 
     Programmed ribosomal frameshift signals on an mRNA cause translating 
ribosomes to shift reading frame, usually by a single nucleotide in the 5’ (-1) or 3’ 
(+1) direction, and continue elongation in the new frame (Brierley, 1995; Dinman, 




al., 2002).  This is termed Programmed Ribosomal Frameshifting (PRF) because the 
frameshift is non-random; it is directed by specific signals contained in the mRNA 
message.  This type of recoding occurs during elongation.  PRF is utilized in a wide 
variety of organisms and can be used to regulate gene expression as well as a range of 
cellular processes.  
 
Programmed -1 Ribosomal Frameshifting 
     Programmed –1 ribosomal frameshifting is utilized by animal, plant, and fungal 
viruses, bacteriophages and some cellular genes.  This list includes mammalian 
retroviruses, coronaviruses, astroviruses, arteriviruses, and toroviruses; fungal 
totiviruses; plant viruses such as tetraviruses and tombusviruses; T7 (Condron et al., 
1991) and λ (Hayes and Bull, 1999) (Levin et al., 1993) bacteriophages; bacterial 
insertion sequences (Chandler and Fayet, 1993); and  dnaX in E.coli (Blinkowa and 
Walker, 1990).  Programmed –1 ribosomal frameshifting (-1 PRF), as it applies to 
eukaryotic systems, will be the form of recoding focused on here.  –1 PRF was first 
discovered in Rous sarcoma virus, where the frameshift allows for the production of 
the gag-pol fusion protein (Jacks and Varmus, 1985).  The majority of confirmed –1 
frameshift signals are found in RNA viruses.  A consensus has been defined for the 
basic components of all known eukaryotic viral –1 frameshift signals ranging from 
the relatively simple yeast L-A virus to a more complex virus such as HIV-1.   
 
    Although the molecular mechanism of –1 PRF is not completely understood, the 




characterized.  The frameshift signal is always found to contain a slippery-site, a 
spacer region and a downstream stimulator such as mRNA secondary structure, most 
commonly a pseudoknot.  The ‘simultaneous slippage model’ (Jacks and Varmus, 
1985; Jacks et al., 1988) was proposed to explain how this signal directed 
frameshifting occurs.  The mRNA pseudoknot directs the translating ribosome to 
pause (Tu et al., 1992; Somogyi et al., 1993), and the spacer region ensures that the 
pause occurs with the ribosome bound amino-acyl and peptidyl tRNAs paired at the 
slippery site (Figure 1.9). The slippery site is a heptameric sequence described as X 
XXY YYZ where X’s are any three identical nucleotides, Y’s are all A or all U, and 
Z is not G.  In the zero frame, the XXY and YYZ codons are base paired with their 
cognate tRNAs in the P- and A-sites respectively.  The sequence of the slippery site is 
such that as the ribosome pauses, the ribosome-bound tRNAs can slip back one 
nucleotide in the –1 direction and all non-wobble bases can correctly re-pair with the 
mRNA.  Peptidyl transfer occurs locking the new frame into place and the 
pseudoknot melts out enabling the ribosome to continue elongation in the –1 frame 
(Harger et al., 2002; Plant et al., 2003).  
 
     The yeast L-A virus is a well-studied model system for understanding –1 PRF 
(Figure 1.10).  The L-A viral genome consists of a double stranded RNA (dsRNA) 
containing two overlapping open reading frames (ORFs) joined by a –1 PRF signal.  
The first ORF encodes Gag, the capsid protein, and the downstream ORF encodes 
Pol, the viral RNA dependant RNA polymerase (RDRP) (Dinman et al., 1991).  If no 










encounters the frameshift signal and slips back one nucleotide in the 5' direction to 
continue translating in the –1 frame, a Gag – Pol fusion protein is produced.  The 
ratio of Gag to Gag-Pol proteins is dictated by –1 PRF efficiency.  The L-A virus 
supports a satellite virus named M1.  It encodes no enzymatic or structural proteins of 
its own and relies completely on L-A for capsid and RDRP proteins.  M1 has a small 
dsRNA genome that encodes a secreted protein toxin and immunity to that toxin.  
Cells harboring the L-A and M1 viruses excrete the toxin killing surrounding M1 
minus yeast cells, thereby conferring a growth advantage and an easily assayable 
phenotype (Figure 1.10).  Increases or decreases in –1 PRF have been shown to 
disrupt viral particle formation interfering with L-A and M1 virus propagation 
(Dinman and Wickner, 1992).     
 
     Programmed –1 ribosomal frameshift signals have also been found in cellular 
genes of higher eukaryotes.  The mouse embryonal carcinoma differentiation 
regulated (Edr) gene, a developmentally regulated mammalian gene, utilizes –1 PRF 
for production of its C-terminal end (Shigemoto et al., 2001; Manktelow et al., 2005). 
The human paraneoplastic antigen Ma3 gene contains a functional –1 PRF signal first 
identified through a bioinformatic approach (Wills et al., 2006).  The exact function 
of this gene as well as the role of its –1 PRF frameshift signal is so far unknown, 
however, Ma3 is expressed in the brain and testis and immunity to Ma3 is associated 











Programmed +1 Ribosomal Frameshifting 
     Programmed +1 Ribosomal Frameshifting (+1 PRF) results in a translational 
reading frame shift of one nucleotide in the 3' direction.  Although the precise 
mechanisms differ, +1 PRF signals are composed of a slippery sequence in the  
mRNA and a stimulator that enhances frameshifting.  +1 PRF signals can be found in 
retrotransposons and in both prokaryotic and eukaryotic genes (Farabaugh, 1996).  
There is also a high frequency of +1 PRF signals found in ciliates (Aigner et al., 
2000; Klobutcher and Farabaugh, 2002).     
 
     One of the first examples of programmed +1 frameshifting was identified in E. 
coli and occurs in the prfB gene, which encodes the peptide release factor 2 (RF2).  
prfB gene expression is negatively regulated by its +1 PRF signal.  The frameshift 
signal consists of a slippery site sequence of CUU UGA C10.  The CUU occupies the 
ribosomal P-site paired to a peptidyl-tRNA and the UGA codon occupies the vacant 
A-site.  If there is sufficient RF2 present in the cell, the stop codon is immediately 
recognized and termination takes place.  If the RF2 abundance is low, the ribosome 
pauses allowing the peptidyl-tRNA:ribosome complex to shift one nucleotide in the 3' 
direction thus avoiding the stop codon.  Translation continues in the +1 frame and 
more RF2 is produced.  Experiments in vitro, show that over expression of RF2 
decreases the +1 PRF for the prfB gene, and that expression of defective RF2 
increased +1 frameshifting to almost 100% in vivo (Craigen and Caskey, 1986; Donly 
et al., 1990). 
                                               




     The yeast Ty1 retrotransposon +1 PRF signal has a slippery sequence comprised 
of CUU AGG C11 (Figure 1.11).  The CUU occupies the ribosomal P-site paired to a 
peptidyl-tRNA and the AGG codon occupies the vacant A-site.  The AGG codon is 
decoded by the low abundance tRNAArg.  The elongating ribosome pauses, waiting 
for the rare tRNAArg.  This pause increases the chance for the petidyl-tRNA occupied 
ribosome to slip forward one nucleotide such that the GGC codon now occupies the 
vacant A-site.  This GGC codon corresponds to an abundant tRNAGly.  
Accommodation of the tRNAGly occurs and translation elongation continues in the 
new +1 reading frame.  Five fold over expression of hungry codon tRNAArg caused a 
43-fold decrease in +1 PRF (Belcourt and Farabaugh, 1990).  Likewise, deletion of 
the hungry codon tRNAArg caused +1 PRF to approach 100% (Kawakami et al., 
1993). 
  
     All known antizymes require +1 PRF for their gene expression (Ivanov et al., 
2000).  An example in higher eukaryotes is rat ornithine decarboxylase (ODC) 
antizyme (Matsufuji et al., 1995).  Ornithine decarboxylase converts ornithine to 
putrescine, and is the rate-limiting step in polyamine biosynthesis (Pegg, 1986).  
ODC antizyme regulates ODC expression by binding to ODC dimers causing them to 
dissociate and targeting them for degradation (Hayashi and Murakami, 1995).  ODC 
antizyme gene expression is regulated by a +1 PRF signal whose efficiency is 
regulated by polyamines (Rom and Kahana, 1994).  Full length active ODC antizyme 
is only produced in the event of a +1 frameshift which is regulated by polyamine 
concentrations.
                                               












     Nonsense suppression, also called stop codon read-through, occurs when a 
termination codon is decoded either by a natural suppressor tRNA (non-programmed) 
or by stop codon redefinition (programmed), and subsequent translation continues in 
the 3’ direction.  The stop codon can be redefined as a natural amino acid or as an 
unusual amino acid such as selenocystein or pyrrolysine12 (Hatfield and Gladyshev, 
2002).  Different organisms utilize programmed nonsense suppression for the 
production of certain genes including viruses (Skuzeski et al., 1991) and Drosophila 
(certain developmental genes oaf, kelch and hdc) (Robinson and Cooley, 1997; 
Steneberg and Samakovlis, 2001).   
 
     Non-programmed nonsense suppression (the term 'nonsense suppression' will be 
used throughout this text for simplicity) allows the formation of multiple polypeptides 
from one message and is utilized extensively by RNA viruses.  Naturally occurring 
nonsense suppressor tRNAs are found in prokaryotes and eukaryotes including yeast 
and mammals and serve to decode the stop codons.  All known nonspecific nonsense 
suppressor tRNAs are cellular tRNAs that also decode cognate codons. Consequently, 
unconventional codon:anti-codon interactions are required for nonsense suppression.  
Suppressor tRNAs vary.  For example, the UAG stop codon can be decoded by 
tRNAGln with a CUG anticodon in S. cerevisiae, and by tRNATyr with an anti-codon 
of GΨA in Drosophila.  Viruses that utilize stop codon read-through infect a wide 
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range of hosts including plants (tomato bushy stunt virus, TBSV) and animals 
(murine leukemia virus, MuLV).  MuLV utilizes stop codon read-through for its 
reverse transcriptase production.  As the sole means of reverse transcriptase enzyme, 
nonsense suppression is required for viral propagation.  The precise mechanism of 
nonsense suppression is not fully known. However, the surrounding sequence and 
structural environment of both the mRNA stop codon and nonsense suppressor 
tRNAs are crucial for nonsense suppression (Kuchino and Muramatsu, 1996; Beier 
and Grimm, 2001).  It has been suggested that interactions between the mRNA 
surrounding the stop codon with the ribosomal small subunit rRNA may be involved 
(Namy et al., 2001).    
 
     Defects in stop codon read-through can occur through two distinct mechanisms.  
The first is a decrease in fidelity resulting in misincorporation events such that a near 
or non-cognate tRNA can more easily decode a stop codon.  The second involves a 
reduction in the efficiency and accuracy of the termination machinery itself.  
Mutations that lead to increase rates of stop codon read-through have been identified 
on both the large and small subunits of the ribosome.  On the small subunit rRNA, 
mutation C1054A in E. coli (Pagel et al., 1997), and its yeast counterpart (Chernoff et 
al., 1996) were shown to cause increased rates of nonsense suppression.  In E. coli, 
these effects were shown to be caused by decreased rates of association of the release 
factor to the ribosome (Arkov et al., 2000) and of subsequent peptidyl-tRNA 




mutation G1093A in the GTPase center of the ribosome also results in increased 
nonsense suppression (Arkov et al., 2002). 
 
Summary 
     The ribosome is a complex machine made of rRNA and proteins that performs the 
translation process efficiently and accurately.  Biochemical and kinetic studies along 
with new advances in ribosome x-ray crystal structures have allowed researchers to 
begin the tremendous task of understanding the process of translation and the 
underlying mechanics of the ribosome.  Despite the myriad of recent advances, there 
are still may questions left unanswered.  This dissertation seeks to elucidate the 
effects of changes in ribosomal RNA on the translational fidelity and structure of 
ribosomes in S. cerevisiae.  Chapter 2 explores the effects a histone deacetylase 
which causes defects in rRNA processing, has on cell growth and translational 
fidelity.  Chapter 3 investigates the affect modified rRNA residues in the peptidyl 
transferase center of the yeast ribosome have on ribosome structure and the resulting 
translational fidelity in yeast.  Chapter 4 discusses how changes in ribosome structure 
can lead to changes in fidelity for different stages of the translation cycle, as well as 









Chapter 2: Delayed rRNA processing results in significant 
ribosome biogenesis and functional defects 
 
Introduction 
 A growing yeast cell devotes a large amount of energy and resources to the 
production of ribosomes, each of which must be able to translate mRNAs with 
extremely high accuracy (Warner, 1999).  Although a premium has been placed on 
fidelity of the translational apparatus, programmed recoding events, such as -1 PRF, 
provide a convenient means to probe the molecular mechanisms underlying ribosome 
structure/function relationships as well as providing a unique window into the 
translation elongation cycle.  There are a number of parameters that can influence the 
ability of ribosomes to maintain translational reading frame (Harger et al., 2002).  
These include: changes in the residence time of ribosomes at a particular PRF signal, 
and the precise step of the elongation cycle that such a kinetic change might occur; 
changes in the stabilities of ribosome-bound tRNAs due to alterations in intrinsic 
ribosomal components such as ribosomal proteins and rRNAs; and defects in the 
abilities of ribosomes to recognize and correct errors.  In combination with the current 
high-resolution structural understanding of ribosomes, this approach is leading to new 
insights into ribosome structure/function relationships.  
 
 In the course of these studies, alleles of several yeast chromosomal genes have 
been characterized that specifically increase -1 PRF efficiency.  Nine chromosomal 
mof mutants (Maintenance Of Frame) were originally described (Dinman and 




of other translation-associated genes with Mof - phenotypes have also been identified 
(Jones et al., 1995; Balasundaram et al., 1994; Dinman and Kinzy, 1997; Ruiz-
Echevarria et al., 1998; Meskauskas and Dinman, 2001).  Concomitant loss of the 
killer virus occurs in strains harboring the mof1-1, mof2-1, mof4-1, mof5-1, mof6-1 
alleles (Dinman and Wickner, 1994).  MOF2 and MOF4 are allelic to SUI1 (Cui et 
al., 1998) and UPF1 (Cui et al., 1996) respectively.  This work focuses on the cloning 
and characterization of MOF6.  We show that mof6-1 is an allele of RPD3, the well-
characterized histone deacetylase, that is involved in transcriptional activation and 
silencing (Struhl, 1998; Suka et al., 1998).  The defect is dependent on the histone 
deacetylase activity of the gene product, and can be rescued by the human homolog, 
HDAC1. Expression of the mutant rpd3 alleles results in delayed exit from lag-phase 
growth and premature auxotrophic shift, suggestive of a defect in carbon source 
mobilization and utilization. The frameshifting defect is most pronounced in early log 
phase, when demand for newly synthesized ribosomes is greatest. The demonstration 
that deletion of either the SIN3 or the SAP30 genes (Sun and Hampsey, 1999) also 
promoted frameshifting and virus maintenance defects suggests a heterochromatin-
associated defect. Processing of the 35S precursor-rRNA was delayed in isogenic 
strains harboring mutant rpd3 alleles and in cells containing gene knockout alleles of 
SIN3 and SAP30.  In actively growing cells, this delay in rRNA processing appears to 
be the primary event that results in a 60S ribosomal subunit biogenesis defect.  The 
resulting unstable ribosomes have specific aminoacyl-tRNA binding defects that 
result in decreased peptidyl transferase activities. This in turn results in decreased 




to slip. We suggest that the heterochromatic-associated Rpd3p/Sin3p/Sap30p 
complex (Sun and Hampsey, 1999) could be physically involved in helping to 
coordinate a very early and critical step in the ribosome biogenesis process.  
Alternatively, abrogation of the function of this complex may result in repression of 
synthesis of the snoRNAs responsible for modification of bases in the large subunit 
rRNA that are associated with A-site.  Lastly, the observed phenotypic defects may 
result from an uncharacterized function of Rpd3p involving direct modification of 
ribosomal or other proteins associated with the ribosome biogenesis machinery. 
 
 
Materials and Methods 
Strains, media, and genetic methods  
     The S. cerevisiae strains used in this study are presented in Table 2.  
Oligonucleotides were synthesized and purchased from Integrated DNA Technologies 
(IDT) and are listed in Table 4.  DNA sequence analysis was performed by the 
RWJMS DNA Synthesis and Sequencing Laboratory.   E. coli strains DH5∀ and 
MV1190 were used to amplify plasmids, and E. coli transformations were performed 
using the standard calcium chloride method as described previously (Sambrook et al., 
1989).  Yeast were transformed using the alkali cation method (Ito et al., 1983).   
YPAD, YPG, SD, synthetic complete medium (H-) and 4.7 MB plates for testing the 
killer phenotype were used (Wickner and Leibowitz, 1976).  Cytoduction of L-A and 
M1 from strain JD758 into rho-o strains were as previously described (Dinman and 




and Roche. T4 DNA ligase and T4 DNA polymerase were obtained from Roche, and 
precision Taq polymerase was obtained from Qiagen. Radioactive nucleotides were 
obtained from NEN.  Dr. Michael Hampsey generously provided the rpd3), sin3∆, 
and sap30∆ yeast strains, and the transcription derepression defective ume6 strains 
were gifts from Dr. Andrew Vershon. 
 
     To monitor temperature sensitivity, cells were grown to saturation and equal 
numbers, spotted on selective media and grown at either the permissive temperature 
(30°C) or the restrictive temperature (37°C) for 3 days. Lack of, or severely reduced 
growth was indicative of temperature sensitivity.  Similarly, 10-fold serial dilutions of 
cells were spotted onto medium containing sparsomycin (5µg/ml), anisomycin 
(5µg/ml), or paromomycin (800µg/ml) to monitor sensitivities to these drugs.  To 
monitor sensitivity to cycloheximide, cells were grown to saturation and 0.1 OD595 
were spread on selective media.  A sterile filter disk containing 100ng of 
cycloheximide was placed in the center of each plate.  Cells were grown for three 
days and zones of growth inhibition measured. 
 
     The killer virus assay was done by replica plating S. cerevisiae colonies onto 
4.7MB plates (Wickner and Leibowitz, 1976) with a freshly seeded lawn of strain 
5x47 (0.5 ml of a suspension at 1 unit of O.D.550 per ml per plate). After 2-3 days at 
20ΕC, killer activity was observed as a zone of growth inhibition around the killer 
colonies.  dsRNA of L-A and M1 viruses were prepared as described (Fried and Fink, 




denaturing agarose gels and visualized by ethidium bromide staining.  RNA blotting 
was used as previously described (Dinman and Wickner, 1994) to monitor the 
abundance of L-A and M1 dsRNAs. 
 
Plasmid and strain constructs, programmed ribosomal frameshift, and 
transcriptional derepression 
     A YCp50 based S. cerevisiae genomic library was purchased from ATCC (Rose et 
al., 1987).  The genomic clone that complemented the mof6-1 ts- phenotype was 
given the name pJD155.   Subclones of pJD155 were generated by partial digestion 
with EcoR I, and self ligated using the Roche rapid ligation kit.   The pRS series of 
plasmids have been previously described (Sikorski and Hieter, 1989; Christianson et 
al., 1992).  Full length RPD3, PEX6, and AAD14 genes were amplified from genomic 
DNA from JD932D by polymerase chain reaction using the oligonucleotide primers 
1+2 (rpd3 alleles), 3+4 (PEX6), and 5+6 (AAD14) (See Table 2B), cloned into 
pRS314 and pRS316, and were designated pRPD3, pPEX6 and pAAD14.  The mof6-
1 allele was amplified from genomic DNA obtained from strain JD469-2C using 
primers 1+2.  PCR reactions using the oligonucleotide primers 1+2 were carried out 
under the following conditions:  Denaturation of dsDNA for 30 seconds at 95OC, 
annealing at 48OC for 45 seconds, 4 min elongation.  PCR products were purified 
using a Qiagen kit, digested with Xho I and Pst I, and were ligated into pRS314, or 
pRS316 (Sikorski and Hieter, 1989).  PCR reactions using oligonucleotide primers 
3+4 (PEX6) or 5+6 (AAD14) were carried out under the following conditions: 30 




elongation time.  PCR products were purified using a Qiagen kit, digested with Kpn I 
and Sal I (PEX6), or Xho I and Pst I (AAD14), and ligated into pRS314.  To make 
pHDAC1, the 1.5 kb Bam HI fragment containing the HDAC1 cDNA (a generous gift 
from Dr. S. L. Schreiber) was excised from pBJ5/HDAC1-F (Taunton et al., 1996) 
and inserted into Bam HI digested pG-1 (Schena and Yamamoto, 1988), thus placing 
the human gene under control of the constitutive yeast PGK1 promoter.  The 
synthetic oligonucleotide H151A (Table 2B) was used to create pH151A using 
standard methods (Kunkel, 1985).  Subcloning PEX6 into pRS306 (Sikorski and 
Hieter, 1989) generated plasmid pPEX6, which was used to integrate the URA3 into 
the PEX6 locus of yeast strain LNY95.  pRPD3, pSIN3 and pSAP30 were generous 
gifts from Dr. M. Hampsey. 
 
 Plasmids p-1 and p0, which were used to monitor programmed ribosomal 
frameshifting, have been described previously (Tumer et al., 1998).  Briefly, in these 
plasmids, transcription is driven from the yeast PGK1 promoter into an AUG 
translational start site.  The E. coli lacZ gene serves as the enzymatic reporter, and 
transcription termination utilizes the yeast PGK1 transcriptional terminator.  In the p0 
plasmids, lacZ is in the 0-frame with respect to the translational start site, and 
measurement of ∃-galactosidase activity generated from cells transformed with these 
plasmids serve as the 0-frame controls.  In the p-1 series, lacZ is in the -1 frame with 
respect to the translational start site, and is 3' of the L-A programmed -1 ribosomal 
frameshift signal such that ∃-galactosidase can only be produced as a consequence of 




frameshifting is calculated by determining the ratio of ∃-galactosidase activity 
produced by cells harboring either p-1 divided by the ∃-galactosidase activity 
produced by cells harboring p0, and multiplying by 100%.   All assays were 
performed in triplicate. 
 
 Plasmids pAV73 and pAV138 were used to monitor transcriptional 
derepression in cells harboring alleles of RPD3 (Vershon et al., 1992).  pAV73 is a 
URA3, 2µ, CYC-LacZ fusion reporter plasmid that is used as a control to establish a 
baseline.  PAV138 contains a URS1 site from the HOP1 promoter cloned into the 
Xho I site of pAV73.  It represses lacZ expression in a Ume6p/Sin3p/Rpd3p 
dependent manner.  The pAV73/pAV138 ratios of β-galactosidase activities were 
used to calculate the ability of the RPD3 variants to derepress lacZ reporter gene 
transcription as previously described (Vershon et al., 1992).  All assays were 
performed in triplicate. 
 
 in vivo [35S]Methionine Incorporation 
     Labeled methionine incorporation assays were performed as previously described 
(Carr-Schmid et al., 1999).  Briefly, isogenic rpd3Δ strains containing wild type 
pRPD3 or pmof6-1 were grown in 30 ml of -met -trp medium at 30°C to an O.D.595 of 
1.0.  Unlabeled methionine was added to a concentration of 50 µM and 
[35S]methionine and [35S]cystine (Expre35S35S Label, NEN Life Science Products) 
were added to each culture to final specific activities of 1.1 µCi/mL.   Samples were 




labels was monitored by cold trichloroacetic acid precipitation.  For each time point, 
1.2 mL aliquots were harvested from which 0.2 mL was used to determine the O.D.595 
of the cultures.  One ml of ice-cold 20% trichloroacetic acid (TCA) was added to the 
remaining 1 ml of each aliquot, incubated on ice for 10 min, heated to 70°C for 
20 min, and filtered through pre-wet Whatman GF/C filters.  Filters were sequentially 
washed with 10 ml of ice cold 5% TCA and 10 ml of 95% ethanol, dried, and 
radioactivity of samples was determined by scintillation counter.   All time points 
were taken in triplicate.  Experiment performed in duplicate. 
 
Pulse-Chase Labeling of rRNA 
     Pulse-chase labeling with L-[methyl-3H]methionine was carried out on the 
isogenic wild-type, mof6-1, rpd3∆, rpd3-H151A, sin3∆, and sap30∆ strains as 
previously described (Dunbar et al., 1997; Lee and Baserga, 1999).  Twenty thousand 
cpm per sample was resolved on a 1.2% formaldehyde-agarose gel. Labeled RNAs 
were transferred to a zeta-probe membrane (Bio-Rad), sprayed with EN3HANCE 
(Dupont), and exposed to x-ray film. 
 
Polysome and 2-dimensional NEPHGE analyses 
     For polysome analyses, cytoplasmic extracts, prepared as described by (Baim et 
al., 1985), were fractionated on 7% - 47% sucrose gradients buffered with 50 mM 
Tris-acetate, pH 7.4, 50 mM NH4Cl, 12 mM MgCl2, 1 mM DTT. Gradients were 
centrifuged in an SW41 rotor at 40,000 rpm for 135 min at 4°C, fractionated and 




NEPHGE analyses, 40S and 60S  ribosomal subunits were separated by 
ultracentrifugation through a 7% - 27% sucrose gradient in the presence of 500mM 
EDTA.  Purified ribosomal subunits (≈195 µg /sample) were separated by non-
equilibrium pH gradient gel electrophoresis (pH gradient of 3.5% -- 11.5% in the first 
dimension, 12.5% polyacrylamide separating gel in the second dimension) and were 
visualized by silver staining by the Kendrick Laboratories (Madison WI). 
 
Preparation of tRNAs and of donor and acceptor fragments 
     Yeast tRNAs were charged with [14C]phenylalanine as previously described 
(Harris and Pestka, 1973; Meskauskas and Dinman, 2001).  Briefly, a 400 µl reaction 
mix composed of 200 Φg of yeast tRNA (Sigma), 25 mM Tris-HCl pH 7.5, 20 mM 
MgCl2, 10 mM ATP, 50 nmol phenylalanine (313 mCi/mmol, NEN), 50 µl 
aminoacyl-tRNA synthetase (Sigma, 9U/ml)  was incubated for 25 min at 37ΕC. 
After addition of 40 ml of 3M sodium acetate (pH 5.0) the mixture was extracted 
twice with an equal volume of water-saturated phenol and once with chloroform.   It 
was then precipitated with 2.5 vol of ethanol at –20ΕC for 1 hour.  After 
centrifugation for 10 min, the pellet was resuspended in 50 ml of 2 mM potassium 
acetate (pH 5.0).  [14C]Phe-tRNAPhe was separated from uncharged tRNAs by anion 
exchange chromatography (DEAE).  Acetylation of charged tRNAs was performed as 
previously described (Haenni and Chapeville, 1966).  Briefly, [14C]Phe-tRNAPhe  was 
resuspended in 200 µl of 0.2 M sodium acetate (pH 5.0) followed by addition of 2.5 




anhydride was added and incubation at 0ΕC continued for an additional hour. The 
tRNA was precipitated by addition of 2.5 vol of ethanol.  The  [14C]Phe-tRNAPhe and 
acetyl-[14C]Phe-tRNAPhe were subsequently digested with 500U of RNase T1 in 200 
µl of 0.3 M sodium acetate (pH 5.0) for 1 hour at 37ΕC, and the reaction mixtures 
were purified using DEAE Sephadex as previously described (Pestka et al., 1970).  
The resulting A-site specific [14C]Phe-CACCA (acceptor) and P-site specific acetyl-




Purification of ribosomes and tRNA binding assays 
     Salt washed ribosomes were purified as previously described (Merrick, 1979; 
Meskauskas and Dinman, 2001).  Briefly, yeast cells were grown in 0.5 L of YPAD 
overnight, collected by centrifugation, and washed twice with buffer A (20 mM Tris-
HCl pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.1 mM EDTA, 0.25 M sucrose).  The cell 
pellet was suspended in 20 ml of buffer A, 30g of glass beads (0.45mm diameter) 
were added, and cells were disrupted by vortexing.  The yeast lysate was centrifuged 
twice for 15 min at 15,000 rpm in a Sorvall S34 rotor, and the supernate was pelleted 
at 100,000 x g for 3 hrs.  The pellet was suspended in 6 ml of buffer B (20 mM Tris-
HCl pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.1 mM EDTA, 0.25 M sucrose, 0.5 M 
KCl), and placed on a cushion of 3 ml of buffer C (20 mM Tris-HCl pH 7.5, 10 mM 
MgCl2, 1 mM DTT, 0.1 mM EDTA, 1 M sucrose, 0.5 M KCl). After centrifugation at 
50,000 rpm for 4 hours (SW55 Ti) the pellet was dissolved in 1 ml of buffer A. After 




19 pmol ribosomes, see (Abraham and Pihl, 1983). Protein content of ribosomes was 
also estimated using Protein Assay Reagent (Biorad). Ribosomes were suspended in 
buffer A at concentration 4 pmol/µl, and stored at –70oC. 
 
 The whole-tRNA and tRNA fragment binding assays followed a modification 
of the previously published protocol (Harris and Pestka, 1973; Meskauskas and 
Dinman, 2001).  Briefly, ribosomes (400 pmol) were incubated with 800 pmol of 
whole tRNAs, donor, or acceptor fragments in 500 µl of a buffer containing 70 mM 
Tris-acetate pH 7.2, 40 mM magnesium acetate, 0.4 M potassium acetate, and 50 mM 
NH4Cl.  Ethanol was added to a final concentration of 30%, and 20Φl aliquots were 
taken during the time course at 24ΕC.  Samples were diluted to 1ml with cold buffer 
(50 mM Tris-HCl, pH 7.2, 0.4 M KCl, 40mM MgCl2, 30% Ethanol), immediately 
precipitated onto a Millipore filter, washed with 1 ml of the dilution buffer, and 
counted in a scintillation counter. The reaction mix without ribosomes was used as 
control.  All assays were performed in triplicate. 
 
Puromycin reaction with tRNA fragments 
Puromycin reactions were performed as previously described (Diedrich et al., 
2000) with slight modifications.  Ribosomes (20 pmol) were incubated with 5 pmol of 
CACCA[14C]AcPhe (682 d.p.m./pmol) in 300 µl of PR Buffer [25 mM HEPES-KOH 
pH 7.4, 135 mM NH4Cl, 250 mM KCl, 20 mM MgCl2, 33% EtOH] at 0o C for 10 
min. Puromycin was added to final concentrations of 1 mM, and reaction mixtures 




reactions stopped by the addition of equal volumes of a 0.3 M NaOAc solution 
saturated with MgSO4. Puromycin was extracted with 1 ml of EtOAc and the 
radioactivity was determined by liquid scintillation counting. In all the studies 
controls were performed in the absence of puromycin to determine the nonspecific 
extraction of CACCA[14C]AcPhe. Control values (generally less than 2%) were 




mof6-1 is an allele of RPD3 
     The ts– phenotype of mof6-1 cells (Dinman and Wickner, 1994) provided a simple 
selective trait for the cloning of the wild type gene.  mof6-1 cells (JD469-2D) 
transformed with a YCp50 based genomic library(Rose et al., 1987) were replica 
plated to selective media and subsequently shifted to non-permissive temperature 
(37°C).  Approximately 1.2 x 104 colonies were screened (4.8 genome equivalents) 
and three that grew at the restrictive temperature were isolated.  Positive plasmids 
were rescued from yeast into E. coli, and reintroduction into mof6-1 cells confirmed 
their abilities to confer growth at the non-permissive temperature.  The inserts in all 
of the genomic clones were approximately thirteen Kb in length, and sequence 
analysis mapped them all to the same region of chromosome XIV.  One of the 
genomic clones, pJD155, was used for the subsequent characterization of MOF6.    
Meiotic linkage analysis was used to ascertain whether pJD155 harbored MOF6 as 




locus of a MOF6 ura3 strain (JD 972A) (Figure 2.1a), providing a scorable phenotype 
for genetic linkage analyses.  Diploid cells (JD972A x JD469-2D) were sporulated, 
and the genotypes of 26 tetrads were determined.  All of the tetrads scored as parental 
ditypes, i.e., 2:2 segregation of Ura+ ts+: Ura– ts–.  The absence of crossover events 
demonstrates tight genetic linkage between the MOF6 and the site of URA3 
integration (PEX6), confirming that MOF6 was present in the yeast genomic DNA 
insert of pJD155. 
 
 Partial restriction analysis of pJD155 revealed four Eco RI restriction 
fragments, which were designated A, B, C, D based on their relative mobilities 
(Figure 2.1a).  All subclones generated from partial Eco RI digestion which did not 
contain the B fragment were unable to complement the temperature sensitive 
phenotype (e.g. pJD155.CAD). Sequence analysis revealed that the B fragment 
contained RPD3. To determine whether MOF6 is RPD3, or whether the B fragment 
contained other genetic information required for transcription initiation or 3' end 
formation of flanking genes, clones of the individual open reading frames that were 
present on the genomic clone were generated by PCR as described in Materials and 
Methods.  mof6-1 cells harboring either pJD155 or pRPD3 but not pPEX6 or pAAD14 
were able to grow at restrictive temperatures (Figure 2.1).  Further, an RPD3 clone 









phenotype, confirming that RPD3 is both necessary and sufficient to complement the 
mof6-1 ts– phenotype (Figure 2.1).  .  
 
     Programmed ribosomal frameshifting assays were used to examine whether 
pRPD3 could complement the mof6-1 frameshifting defect.  The frameshift test 
plasmids p-1 and the 0-frame control p0 were introduced into mof6-1 cells harboring 
pRPD3, pPEX6, pAAD14, or pmof6-1 and the affects on -1 PRF were assayed.  
Whereas introduction of the wild-type gene pRPD3 restored –1 PRF efficiencies to 
wild type levels (approximately 2.0%), frameshifting efficiencies remained elevated 
in cells harboring the other clones (Figure 2.1a).  Sequence analysis of mof6-1 clones 
isolated from three independent PCR reactions revealed the presence of a single base 
transition, G1218A, corresponding to change at the amino acid level of aspartatic acid 
to asparagine (GAT à AAT) at position 407, approximately 30 residues from the C-
terminus of the protein (data not shown).  A ClustalW analysis (Thompson et al., 
1994) reveals that yeast has an acidic residue at this position while the RPD3 
homologs from humans, mice and Arabdopsis contain the basic arginine, suggesting 
that there may be a requirement for a charged residue in this environment.  
Unfortunately, the lack of structural information pertaining to this region of the 
protein precludes additional speculation on the functional role of this amino acid 
residue. 
 
 Two additional plasmid-borne rpd3 alleles were constructed for further 
studies.  Since the mof6-1 mutation did not occur in the putative deacetylation motif 




position 151 to an alanine residue (pH151A), which was previously shown to nearly 
abrogate Rpd3p deacetylase activity (Kadosh and Struhl, 1998).  In addition, since 
HDAC1 is the most homologous of the at least seven different human histone 
deacetylases to RPD3 (see (Taunton et al., 1996; Wang et al., 1999), we used a clone 
in which transcription of the human HDAC1 cDNA was driven from the yeast PGK1 
promoter (pHDAC1).  In order to further characterize mof6-1 independent of strain-
specific background effects, all subsequent experiments were performed with 
plasmid-borne alleles in a the rpd3::LEU2 gene disruption strain YMH270.  The 
resulting isogenic strains were subsequently transformed with the p-1 and p0 
frameshift test vectors, and -1 PRF efficiencies were determined. Frameshifting 
efficiencies were significantly elevated in cells harboring pmof6-1, pH151A, and 
vector alone, while addition of the wild-type gene or the human homolog reduced –1 
PRF efficiencies to wild-type levels (Figure 2.2a).   
 
To examine the affects of the different rpd3 alleles on killer virus 
maintenance, L-A and M1 were first introduced by cytoplasmic mixing into the rpd3) 
strain harboring the wild-type RPD3 gene on a URA3 based CEN plasmid, and stable 
Killer+ colonies were identified.  The resulting strain was then transformed with low 
copy TRP1 vectors harboring the different RPD3 alleles, or with a vector control.  In 
parallel to the frameshifting results, increased – 1 frameshifting efficiencies 
correlated with loss of the killer phenotype (Figure 2.2b) and with loss of the M1 
satellite virus (Figure 2.2c).  Assays for transcriptional repression (Figure 2.3) and 

















between these classic rpd3-associated phenotypes and defects in programmed –1 
ribosomal frameshifting.   In addition, introduction of pmof6-1into wild-type cells 
had no effect on –1 frameshifting efficiencies, demonstrating that this does not 
represent a gain of function allele (data not shown). Taken as a whole, these data 
define the mof6-1, rpd3-H151A and rpd3) as mof-specific alleles of RPD3. 
 
Correlation of growth and frameshifting defects in the rpd3 mutants 
  It was observed that the initial appearance and subsequent growth of colonies 
of rpd3∆ cells transformed with the various plasmid-borne mutant alleles of rpd3 was 
delayed relative to those containing the wild-type gene.  Measurement of growth rates 
revealed significant quantitative differences.  In logarithmic growth, doubling times 
of cells harboring either vector alone or the pH151A allele were approximately 1.4-
fold longer than wild-type controls.  The growth defect was even greater in mof6-1 
cells where doubling times were increased approximately 1.6-fold compared to 
isogenic wild-type cells.  Shifting cells from stationary phase growth to fresh 
medium, and subsequent monitoring of cell growth rates revealed that the mutants 
also exhibited significantly different effects on the quality of growth as compared to 
isogenic wild-type controls.  Particularly striking was that the mutants remained in 
lag-phase growth for approximately 2 hr longer than wild-type controls (Figure 2.4a), 
suggestive of a defect in the ability of the biosynthetic apparatus to respond to the 
presence of a rich nutrient source. Similarly, the onset of diauxic shift occurred 









pH151A and vector alone as compared to those expression the wild-type gene.  This 
result suggests inefficient utilization of carbon source by the mutants. 
 
     Given the original translation-associated defect of mof6-1, we examined whether 
these cells exhibited any gross defect in protein synthesis.  Rates of incorporation of 
[35S] labeled methionine and cysteine into newly synthesized protein were determined 
in mid-logarithmically growing cells as described in the materials and methods.  The 
results (Figure 2.5) demonstrate that that rates of protein synthesis in mof6-1 cells 
were approximately 75% that of wild-type cells. 
 
     Previous experiments had demonstrated that programmed –1 ribosomal 
frameshifting efficiencies remain stable throughout the growth cycle in wild-type 
cells (Dinman et al., 1991).  In light of the effects of the mutants on cell growth, –1 
PRF efficiencies were monitored during lag-phase, log-phase, and after diauxic shift 
in isogenic rpd3∆ cells harboring vector alone, pRPD3, pmof6-1, and pH151A.  The 
results of these experiments show that –1 PRF defects were maximized in the mutants 
in lag-phase, becoming less severe as cells progressed through the growth curve 
(Figure 2.4b).  The effect was most notable in mof6-1 cells.    The results suggest that 
the frameshifting defects were maximized in the mutants when demand for ribosomes 
was the greatest, and that –1 frameshifting efficiencies decreased in parallel with the 
demand for newly synthesized ribosomes. That no such effect was observed in wild-











biosynthesis (Warner, 1999), and suggests a defect in the regulation of ribosome 
biosynthesis (see below). 
 
Deletion of other genes linked to heterochromatin-associated functions also result 
in the Mof - phenotype 
     Deacetylation of histones by Rpd3p promotes local chromatin condensation, 
resulting in transcriptional repression of nearby RNA pol II transcribed genes 
(reviewed in (Courey and Jia, 2001). Although Rpd3p is able to deacetylate histones 
in vitro, in vivo deacetylation of histones by Rpd3p requires the co-factors.  Mutations 
in any of the components of the Rpd3p/Sin3p/Ume6p repression complex lead to 
gene-specific derepression of RNA pol II regulated genes and concomitant 
transcriptional activation (Hassig et al., 1997; Kadosh and Struhl, 1998).  Conversely, 
mutations in any of the components of the Rpd3p/Sin3p/Sap30p repression complex 
lead to the opposite effect, i.e. enhanced transcriptional silencing of RNA pol II 
transcribed genes artificially inserted into heterochromatin contexts (Sun and 
Hampsey, 1999).   
 
 Given the model describing the histone deacetylase complex, if mof6-1 is 
acting through either of these complexes, then sin3 mutants would also exhibit Mof– 
phenotypes.  Further, if the effect is on a heterochromatin-associated function, e.g. 
transcription or maturation of rRNAs, sap30 mutants should also promote increased –
1 PRF efficiencies.  Conversely, ume6 mutants should promote increased –1 PRF 











genes. Figure 2.6 shows that deletion of either SIN3 or SAP30 resulted in increased -1 
PRF efficiencies, while three separate ume6 alleles did not.  The sin3∆ and sap30∆ 
strains also had significant killer virus maintenance defects, whereas ume6 strains 
were able to stably maintain the killer virus (data not shown).  These results 
demonstrate that 1) the histone deacetylation apparatus is involved in a process that 
results in a specific translational fidelity defect, and 2) the effect is likely to involve a 
process in the heterochromatin environment.   
 
Mutation of genes involved in the histone deacetylation apparatus result in 60S 
ribosomal subunit biogenesis defects 
     That a defect involving heterochromatin should result in a translational fidelity 
defect suggested a ribosome biogenesis defect involving rRNA transcription or 
processing.  Given the involvement of the histone deacetylase complex in 
transcription-associated processes, the effects of these alleles on rRNA transcription 
and processing were examined by pulsing cells with [3H]-methylmethionine, which 
specifically labels the methylated RNAs, the most abundant of which are those 
transcribed from the 35S operon.  Though no differences were observed with regard 
to either the rates of 35S pre-rRNA synthesis, nor in its eventual maturation to 18S 
and 25S rRNAs, the amount of time required for the initial processing step of the 35S 
pre-rRNA in the mutant cells was delayed by approximately 3 min as compared to 
wild-type controls (Figure 2.7).  A steady state analysis revealed that there was no 
accumulation of any precursors in the mutant cells (data not shown).   Polysome 




















isolated from isogenic wild-type, rpd3∆, mof6-1, rpd3-H151A, sin3∆, and sap30∆ 
strains were suggestive of biogenesis defects in the 60S ribosome subunits as 
evidenced by decreased levels of 60S ribosomal subunits, increased areas under the 
80S peaks, and decreased polysome peaks (Figure 2.8).   
 
 Ribosome biogenesis defects are not due to global defects in ribosomal protein 
expression.   
      We have previously found that defects in specific ribosomal proteins result in 
increased programmed ribosomal frameshifting efficiencies (Peltz et al., 1999; 
Meskauskas and Dinman, 2001).  Thus, one possible explanation for the observed 
effects could be that these alleles promote altered expression of ribosomal proteins 
(RPs).  To address this, approximately 200µg samples of 60S and 40S ribosomal 
subunits isolated from isogenic wild-type and mutant cells were separated in two 
dimensions by nonequlibrium pH gradient electorphoresis (NEPHGE), and RPs were 
visualized by silver staining.  No gross differences in the staining patterns were 
observed between wild-type and mutant samples (data not shown).  These results 
demonstrate that the effects of the rpd3 mutants on programmed ribosomal 




The mutants result in aminoacyl-tRNA binding in defects 
     One previously unexplained phenotype of rpd3 mutants has been their sensitivity 









data showing that these classes of mutants promote a ribosome biogenesis defect 
specific to 60S subunits, we employed a pharmacogenetic approach using well 
characterized antibiotics to investigate the specificity of the defects.  Sparsomycin, 
which increases the affinity of ribosomes for the 3’ (donor) end of peptidyl-tRNAs 
(Jayaraman and Goldberg, 1968; Herner et al., 1969; Moazed and Noller, 1991) was 
used as a P-site specific probe.  Anisomycin, which decreases ribosomal affinities for 
the 3’ (acceptor) ends of aminoacyl-tRNAs (Grollman, 1967; Carrasco et al., 1973; 
Schindler, 1974) and, paromomycin, which stabilizes binding of near-cognate tRNAs 
in the decoding center of the small subunit rRNA (Carter et al., 2000; Ogle et al., 
2001; Vicens and Westhof, 2001) served as probes for A-site specific defects.  Figure 
2.9 shows that although sparsomycin had no effect relative to wild type on cells 
harboring the various rpd3 alleles (rpd3∆, mof6-1, and rpd3-H151A), or the sin3∆ 
and sap30∆ mutants, all of the mutants were hypersensitive to anisomycin, and all but 
sap30∆ were hypersensitive to paromomycin.  These data indicate that the 
translational defect caused by mutations in these genes is specific to the ribosomal A-
site.  To further investigate the biochemical basis for these observations, tRNA 
binding experiments were performed comparing isogenic wild-type and mof6-1 
ribosomes.  Although no differences were observed in the binding of the 3’ ends of 
either donor or acceptor fragments (data not shown), the binding profiles for intact aa-
tRNAs were dramatically different (Figure 2.10).  Specifically, mof6-1 ribosomes had 
decreased initial rates of aa-tRNA binding, and had lower overall affinities for aa-
tRNAs.  In addition, precipitous dropoff in aa-tRNA binding at the 60 min time point 















Ribosomes from mof6-1 cells have decreased peptidyl transfer activities 
     We previously demonstrated that peptidyl transfer defects can specifically promote 
increased–1 PRF efficiencies (Dinman et al., 1997).  It is possible that a defect in 
binding of aa-tRNA could result in diminished peptidyl transferase activities.  This in 
turn might enable elongating ribosomes to pause longer at the programmed –1 
ribosomal frameshift signal, providing them with more time to shift.  To test this 
hypothesis, we compared the peptidyl transferase activities of ribosomes isolated 
from isogenic wild-type and mof6-1 strains using the puromycin reaction.  Figure 
2.11 shows that ribosomes purified from mof6-1 cells have significantly reduced 
peptidyl transferase activities as compared to wild-type controls. These findings 




mof6-1 was originally isolated as a recessive mutation in S. cerevisiae that 
promoted increased efficiencies of programmed -1 ribosomal frameshifting and 
rendered cells unable to maintain the killer virus (Dinman and Wickner, 1994).  In the 
present study, we have shown that MOF6 is a unique allele of RPD3, that it does not 
represent a gain-of-function allele, and that the deacetylase function of Rpd3p is 
required for maintaining wild-type levels of frameshifting, maintenance of the yeast 
killer virus, and proper timing and extent of downstream rRNA processing events and 










     We previously demonstrated that peptidyl transfer defects can specifically promote 
sensitivity to translational inhibitors anisomycin and paromomycin, these data suggest 
an A-site specific defect which results in increases in -1PRF.  This frameshifting 
defect is most severe during lag phase of growth, when the demand for ribosomes is 
highest.  Mutant cells also display delayed exit from lag-phase growth in which may 
indicate defects in ribosome production and integrity.  As the demand for new 
ribosomes outpaces the ability of the cell to supply them, the cell would tend to 
produce a greater fraction of defective ribosomes in an attempt to keep up with 
demand.  Additionally, the mutants strains enter into diauxic shift before the wild-
type. These data could suggest that these cells are inefficiently utilizing the carbon 
source in the growth medium due to their functionally compromised ribosomes 
producing a large amount of inaccurately translated, inactive protein products.  Such 
an unproductive use of cellular and environmental resources could account for the 
increased lag time and early entry into diauxic shift. 
 
Specific interactions of the Rpd3p-Sin3p complex with other factors, e.g. Ume6p 
or Sap30p, have been genetically shown to have differential effects on RNA Pol II 
transcribed genes in either euchromatin or heterochromatin environments (Sun and 
Hampsey, 1999).  Our observation that mutants of RPD3, SIN3 and SAP30, but not of 
UME6, affect programmed –1 ribosomal frameshifting and virus maintenance suggest 
that these translation-associated defects are due to effects in the heterochromatin 




synthesis suggesting that defects in ribosome biogenesis and function was not due to 
an rRNA transcriptional defect.  Rather, we have shown that the defect is a delay at 
the earliest stage in the 35S pre-rRNA processing program.  Since processing of the 
35S pre-rRNA is co-transcriptional (Fath et al., 2000), and since the histone 
deacetylase complex is known to influence chromatin structure, one possible 
explanation for our observations could be that deviations from the wild-type 
heterochromatin environment cause defects in the early stages of ribosome biogenesis 
possibly by altered production of the involved machinery.  
 
In light of the well defined steps involved in rRNA maturation (Kressler et al., 
1999; Venema and Tollervey, 1999; Leary and Huang, 2001)our data suggest the 
possibility that the defect may be at the level of rRNA base modification, e.g. 2’-O-
ribose methylation (Nm) and/or pseudouridylation.  These types of base modification 
have been specifically shown to localize to “functional” regions of the ribosome 
(Decatur and Fournier, 2002).  Of particular interest with regard to the ribosomal A-
site specific defect observed here are the large numbers of modified bases clustered in 
regions of the large subunit rRNA that are associated with the A-site/aa-tRNA 
interactions, and the peptidyl transferase center (Decatur and Fournier, 2002; 
Ofengand, 2002).  These include 1) the peptidyl transferase center core region, 2) the 
region of helix 38 that forms an “A-minor motif” with 5S rRNA (Nissen et al., 2001), 
3) helix 69, which appears to form an important bridge between the aa- and peptidyl-
tRNAs (Stark et al., 2002), and 4) the A-loop at the end of helix 92 (though the lack 




affecting this particular structure). Thus, an alternative to the altered heterochromatin 
topology hypothesis could be that a deficiency in the histone deacetylation machinery 
could result in repression of the RNA polymerase II transcribed box C+D and/or box 
H+ACA snoRNAs, which act as essential guides for base-specific rRNA modification 
(Decatur and Fournier, 2002; Ofengand, 2002), resulting in the observed delay in 35S 
rRNA processing.   
 
Whatever its origin, the early delay in rRNA maturation is affecting a series of 
downstream processes involved in the biogenesis and functionality of ribosomes.  
These effects are specific to the formation and/or the function of the A-site. The 
resulting ribosomes are less accurate than their wild-type counterparts and have 





Chapter 3: Effects of rRNA modifications in the PTC of 




     Extensive research into rRNA modification has enabled mapping of the majority 
of Ψ and Nm residues in eukaryotic and archaeal ribosomes, as well as identifying the 
snoRNA molecules that guide their modification.  However, little is understood about 
the functional roles of nucleotide modification.  It is known that nucleotide 
modifications within the ribosome are not located randomly.  This is most clearly 
seen in the ribosomal large subunit (Figure3.1), where modifications cluster in highly 
conserved areas of the ribosome devoted to peptidyl transfer, A- and P site tRNA 
binding sites, the peptide exit tunnel and intersubunit bridges (Samarsky and 
Fournier, 1999; Ban et al., 2000; Yusupov et al., 2001; Decatur and Fournier, 2002).  
This clustering is seen in organisms ranging from E. coli to humans with the number 
of modifications increasing with evolutionary complexity (Ofengand et al., 1995).   
 
     Despite this high degree of conservation, most snoRNAs responsible for guiding 
these modifications can be individually deleted with minimal detriment to the 
organism indicated as small or no change in growth (Lowe and Eddy, 1999; 
Samarsky and Fournier, 1999).  Disrupting/deleting pseudouridine synthase proteins 
responsible for modification of only two or three residues in E. coli did not produce 








 stains in vivo.  However, when grown together the mutants strains were strongly out 
competed by the wild-type suggesting a growth advantage conferred by the 
modifications (Raychaudhuri et al., 1998; Raychaudhuri et al., 1999).  E. coli 
ribosomes reconstituted in vitro without posttranscriptional rRNA modifications are 
severely defective in catalytic activity (Green and Noller, 1996).  Interestingly, global 
disruption of Ψ or Nm formation in vivo results in strong growth defects in yeast, as 
seen resulting from point mutations of yeast modification enzymes Cbf5p and Nop1p; 
proteins encoded by essential genes in yeast (Tollervey et al., 1993; Zebarjadian et 
al., 1999). Modifications found to be essential are often performed by a snoRNP that 
harbors a component also essential for rRNA processing.  These results in aggregate 
suggest that rRNA modifications may be individually dispensable for survival, but 
together serve to optimize rRNA structure for production of accurate and efficient 
ribosomes.       
 
     While it is has become clear that modified residues in ribosomal RNA can 
contribute to ribosome function, how these modified residues accomplish this feat is 
still largely unknown.  Based on the chemical properties of Ψ and Nm residues, 
possible functional roles can be inferred but not established.  It has been suggested 
that Ψ residues contribute to stability by producing increased potential for base 
stacking, as well as by offering an extra hydrogen bond donor as compared to uridine 
(Charette and Gray, 2000; Helm, 2006).  Nm residues offer protection against 
hydrolysis by bases and nucleases and can create structural changes by changing the 




the 3’endo ribose configuration (Williams et al., 2001; Helm, 2006).  Thermodynamic 
and NMR based studies of Ψ containing hairpin RNAs revealed that a Ψ residue is 
stabilizing when located at a stem loop junction and slightly destabilizing when 
located in single-stranded loop regions when compared to unmodified RNAs 
(Meroueh et al., 2000).  Recent NMR studies of the highly conserved and highly 
modified LSU H69 of the human ribosome observed discernable but subtle secondary 
structure differences between rRNA with and without the modifications (Sumita et 
al., 2005). 
 
     Functional and structural studies beyond growth characterization and stability 
measurements have been performed implicating rRNA modification defects as 
causing changes in translation rates and ribosome integrity.  In E. coli, mutants 
lacking methylation of the m1G745 residue located in the LSU exhibit a decreased 
growth rate, decreased rate of polypeptide chain elongation rate, defects in ribosome 
profiles and showed resistance to the antibiotic viomycin (Gustafsson and Persson, 
1998).  In yeast, knockout strains were created which lack each of six snoRNA genes 
that guide pseudouridylation of residues in the PTC of the ribosome, as well as one 
strain that lacked all six genes (King et al., 2003).  The resulting mutants were 
characterized and only one individual mutant, the snR10 deletion strain, had 
phenotypic defects.  However, deletion strains of all six snoRNA genes promoted 
moderate defects in growth and translation rates, sensitivity to the drug paromomycin, 
and changes in ribosome profiles.  These defects were more pronounced in the six 




one or some combination of the additional hypo-modified residues present in the six 
gene deletion strain was necessary to produce the increased severity of phenotypic 
defects seen in the multiple snoRNA deletion strain.  Structure probing experiments 
also revealed altered LSU rRNA structure for the multiple snoRNA deletion strain.  
 
     Other functional studies have centered around two methylated nucleotides, mU2920 
and mG2921, in the A loop of the yeast ribosome.  There are two components thought 
to be involved in the methylation of these rRNA residues: the guide snoRNA snR52, 
and the site-specific methyltransferase Spb1p, an essential yeast nucleolar protein.  
Primer extension analysis revealed a functionally redundant pathway whereby snR52 
or Spb1p could methylate residue Um2920 (Bonnerot et al., 2003).  Later TLC (thin 
layer chromatography) experiments revealed a different mechanism whereby Spb1p 
and snR52 were responsible for methylation of Gm2921 and Um2920 respectively, and 
showing that Spb1p could methylate residue Um2920 in the absence of snR52 (Lapeyre 
and Purushothaman, 2004).  Despite this discrepancy, it is clear that deleting both 
snR52 and Spb1p results in severe defects in growth rates and polysome profiles, as 
well as paromomycin sensitivity (Bonnerot et al., 2003).  This makes Spb1p an 
important exception to the snoRNA guided modification rule in eukaryotes.  The E. 
coli homolog of Spb1p, FtsJ/RrmJ, methylates 23S rRNA residue Um2552 the 
equivalent of yeast Um2920 (Caldas et al., 2000).  Deletion of this protein in E. coli 
results in severe growth defects, temperature sensitivity, and altered ribosome profiles 





     Despite their high level of conservation and distribution in functionally important 
areas of the ribosome, rRNA modifications belie their individual importance with a 
lack of defects in their absence.  However, the changes in ribosome profiles and 
rRNA structures suggest the intriguing possibility that the translation process may 
indeed be altered in some way.  One way to monitor the functional effects associated 
with these ribosomal changes is to assay for changes in translational fidelity.  Here, 
several single and one double deletion strains of previously characterized snoRNAs 
known to modify the PTC of the yeast ribosome were monitored for changes in 
translational fidelity.  The results show that defects in rRNA modification produce 
allele specific mutant phenotypes including increased sensitivity to translational 
inhibitors; defects in virus propagation; changes in translational fidelity as monitored 
by +1 and –1 PRF, aa-tRNA selection and non-specific nonsense suppression; 
changes in the rates of aa-tRNA binding to the ribosomal A-site; changes in rates of 




Materials and Methods 
 
Strains, media, and genetic methods 
     The S. cerevisiae strains used in this study are presented in Table 2.  Escherichia 
coli strain DH5α was used to amplify plasmids (listed in Table 3), and E. coli 
transformations were performed using the high-efficiency transformation method 




et al., 1983). YPAD and synthetic complete medium (H-), as well as YPG, SD, and 
4.7 MB plates used for testing the killer phenotype were prepared and used as 
described previously (Dinman and Wickner, 1994).  Oligonucleotide primers were 
purchased from IDT (Coralville, IA) and are listed in Table 4.  Yeast deletion strains 
snr10Δ, 34Δ, 37Δ, 42Δ, 46Δ and isogenic wild-type were provided by M.J. Fournier.  
Yeast strains snr52Δ, spb1DA, the double mutant and an isogenic wild-type were 
provided by G. Lutfalla. 
 
Killer virus assay and viral dsRNA analyses 
     Cytoduction of the L-A and M1 killer virus into snoRNA knockout strains and 
subsequent killer virus assays were carried out as previously described (Dinman and 
Wickner, 1992). Briefly, viruses were introduced into [rho0] cells by cytoduction, 
cytoplamic mixing without mating.  Cells were streaked for single colonies on 
selective media (-arg).  Colonies were replica plated onto SD, YPG, and 4.7MB 
plates seeded with 5X47 killer indicator cells.  Colonies were scored for growth on 
YPG, and the absence of growth on SD medium.  Killer activity was observed after a 
few days at room temperature as a zone of growth inhibition around the Killer+ (K+) 
colonies.  Total RNAs were extracted from cytoduced wild-type and snoRNA 
knockout strains as previously described (Harger and Dinman, 2003).    Single 
stranded RNA was removed from the total RNA sample by adding 10-20μg total 
RNA and 0.5ng RNase A in 0.5M NaCl, 1X TE and digesting at RT for 30 min. 




phenol (pH 6.6) and chloroform, precipitated, resuspended in deionized water, and 
separated and visualized through an ethidium bromide stained 1% agarose TAE gel.  
 
Dual Luciferase Assays 
     Dual luciferase assays in yeast were performed as previously described (Harger 
and Dinman, 2003).  These involve the use of a 0-frame control reporter and −1, +1 
ribosomal frameshift, nonsense suppression, and misincorporation test reporter 
constructs.  Miscoding efficiencies were calculated by determining the firefly/Renilla 
luminescence ratios from cell lysates expressing each the control and test reporters, 
then dividing the test ratio by the control ratio and normalizing by the wild-type.  At 
least three readings derived from lysates derived from a minimum of three different 
yeast cultures were used.  All assays were performed with enough replicates to 
achieve confidence levels of >95%, and standard errors were calculated as previously 
described (Jacobs and Dinman, 2004).  Luminescence readings were obtained using a 
TD20/20 luminometer (Turner Designs Inc. Sunnyvale, CA). Reactions were carried 





For dilution spot assays, yeast cells grown to logarithmic phase were initially diluted 
to 1 × 106 colony forming units (CFU)/ml. Subsequent tenfold dilutions were made 




or sparsomycin (10 and 20 μg/mL) and incubated at 30°C.  Anisomycin and 
sparsomycin were obtained from Sigma-Aldrich, St. Louis, MO. 
 
Ribosome isolation 
     S. cerevisiae ribosomes were isolated at 4°C as previously described (Meskauskas 
et al., 2005).  Cultures (I L) were grown in YPAD to O.D595=1 , harvested by 
centrifugation and washed 1 time in 40ml cold 0.9% KCl and frozen in liquid 
nitrogen.  Before use, frozen cells were thawed on ice and 40ml cold 0.9% KCl was 
added for a second wash.  Cells were resuspended to a concentration of 1ml/2g pellet 
in Buffer A [20 mM Tris-HCl pH 7.5 at 4o C, 5 mM Mg(CH3COO)2, 50 mM KCl, 
10% Glycerol, and 1mM phenylmethylsulfonyl fluoride (PMSF), 1 mM1,4-
dithioerythritol (DTE) added immediately prior to use].  Add 1 ml equivalent 0.5mm 
zirconia beads to a 2 ml conical tube, then fill with cell solution and vortex at 4°C to 
disrupt using a Mini-bead beater in 2 min bursts, with intermittent 2 min incubation 
on ice.  Repeat two to four times until cell lysis is complete.  Cells were transferred to 
a 5ml polycarbonate centrifuge tube. Beads were washed with Buffer A and wash 
solution containing cells was transferred to the 5ml polycarbonate centrifuge tube 
until full.  Tubes were centrifuged using a Beckman micro-ultracentriguge MLS-50 
rotor 25 min 20,000rpm.  The supernatant was transferred, while avoiding the pellet, 
to a 5ml pollyallomer tube containing a 1 ml cushion of cold Buffer C [20 mM Tris-
HCl pH 7.5 at +4o C, 5 mM Mg(CH3COO)2, 50 mM KCl, 25% Glycerol, and 0.1 mM 
PMSF, 0.1 mM DTE added immediately prior to use].  Samples were centrifuged as 




deceleration settings. The supernatant was discarded and the fines were gently 
washed away from precipitate with 1ml Buffer C.  Ribosomes resuspended in 100 to 
300 μL cold Buffer C w/DTE and PMSF.  Samples were centrifuged for 1 min 12000 
rpm 4°C to clarify lysates.  Supernatants were transferred to a new tube.  Ribosomes 
were aliquoted and stored at -80°C.  Concentrations were determined using optical 
density (1 OD260 = 20 pmol). 
 
Purification of aminoacyl-tRNA synthetases 
     Aminoacyl-tRNA synthetases were purified as previously described with minor 
modifications (von der Haar F., 1979). Two pounds of frozen cake yeast (George R. 
Ruhl & Son, Inc., Hanover, MD) were placed in 500 ml of buffer A [0.2 M Tris-base, 
0.3 M NH4Cl, 20 mM MgSO4, 1 mM EDTA, 0.15 M dextrose] and allowed to thaw 
and ferment overnight. Cells were disrupted by three passages through an ice-cooled 
Microfluidaser at ~18,000 lb/in2, cell debris was removed by centrifugation at 4 °C in 
a Beckman JLA rotor at 10,000 rpm for 30 minutes, and 800 ml of supernatant was 
obtained. Fines and nucleic acids were precipitated by addition of polyethylenimine 
(1.73 g/lb of cells, equivalent to 4.32 g/liter of lysate) over a period of 5 minutes with 
slow stirring. Precipitates were removed by centrifugation at 4 °C using a GSA rotor 
at 9,000 rpm for 40 minutes. Proteins in the supernatant were precipitated by addition 
of 472 g of ammonium sulfate per liter of extract (70 % saturation), and precipitates 
were collected by centrifugation in a GSA rotor at 12,000 rpm for 45 minutes at room 
temperature. The pellet from this step was suspended in 43.75 ml of buffer C [30 mM 




of pellet and subsequently dialyzed in 2 liters of buffer C overnight with two changes 
of buffer. The extract then was clarified by centrifugation in a GSA rotor at 12,000 
rpm for 45 minutes at 4 °C. The supernatant was diluted 2.5 times with buffer C and 
fractionated through a Sephadex CM50 column equilibrated with buffer C. The 
column was washed with buffer D [30 mM potassium phosphate, pH 7.2, 1 mM 
EDTA, 0.01 mM PMSF, 10 % glycerol] with 50 mM KCl. The proteins were eluted 
from the column using a series of step gradients composed of buffer D containing 150 
mM, 300 mM, and 500 mM KCl. The material eluted by buffer D with 150 mM KCl 
contains phenylalanyl-tRNA synthetase activity. Proteins were precipitated by 
addition of 472 g/liter of ammonium sulfate, and pellets were suspended in buffer D 
containing 50 mM KCl. Extracts were dialyzed against 1 liter with two changes of 
buffer D50 for 10 h, after which they were clarified by centrifugation in a GSA rotor 
at 12,000 rpm for 45 minutes at 4 °C. The obtained preparations of aa-tRNA 
synthetases were aliquoted and flash frozen in liquid nitrogen. 
 
 Synthesis of aminoacyl-tRNA and acetylated aminoacyl-tRNA 
     Yeast phenylalanyl-tRNAs were aminoacylated by scaling up a previously 
described method (von der Haar F., 1974). The reaction mix (5 ml) contained 300 
mM Tris-HCl, pH 7.6, 100 mM KCl, 20 mM MgCl2, 0.4 mM ATP, 40 µM [14C]Phe 
[496 mCi/mmole], plus 5 mg of tRNA-Phe and 475 µl of aminoacyl-tRNA 
synthetases (D150) purified as described above. Reaction mixtures were incubated for 
30 minutes at 30 °C, and proteins were removed by extraction with acid-phenol-




by high-performance liquid chromatography (HPLC) as previously described (Triana-
Alonso et al., 2000) with the following modifications. Samples were loaded onto a 
4.6x250 mm JT Baker wide-pore butyl column equilibrated with buffer A [20 mM 
NH4(CH3COO), 10 mM MgCl2, 400 mM NaCl; pH 5.0] at 1 ml/min. The column was 
washed with 10 ml of buffer A, creating conditions under which free phenylalanine 
and aminoacyladenylate are eluted from the column. Uncharged tRNAs were eluted 
by isocratic elution with 19 ml at 15 % of buffer B [20 mM NH4(CH3COOH), 10 mM 
MgCl2, 400 mM NaCl, 60 % methanol; pH 5.0). [14C]Phe-tRNA was eluted using a 
step gradient to 100 % of buffer B. Elution of aminoacyl-tRNA was monitored by 
OD260/280 readings, and [14C]Phe-tRNA peak and concentrations were determined by 
scintillation counting. The presence of aminoacyl-tRNA in the eluted material was 
confirmed by gel filtration through G-25 spin columns and by nonenzymatic 
hydrolysis of ester bonds at basic pH (Kaneko and Doi, 1966). Ac-[14C]tRNA was 
obtained in a similar manner. Yeast phenylalanyl tRNA was charged with [14C]Phe as 
above and extracted with phenol. The [14C]Phe-tRNA was acetylated by addition of 
64 µl of acetic anhydride at 15 minutes intervals for 1 h on ice (Triana-Alonso et al., 
2000). The reaction mix was clarified by centrifugation at 15,000 rpm for 3 minutes, 
and Ac-[14C]Phe-tRNA was purified by HPLC as described above. 
 
Characterization of peptidyl transferase activity 
     Peptidyl transfer assays were performed essentially as previously described 
(Meskauskas et al., 2005).  The protocol was carried out on ice or at 4°C at all times 




was formed by incubating 120 pmol ribosomes, 0.4 mg/ml poly(U), 0.4 mM GTP, 
and 100 pmol Ac- [14C]Phe-tRNA in 200 μL of binding buffer P [80 mM Tris-HCl, 
pH 7.4, 11 mM magnesium acetate, 160 mM ammonium chloride, 6 mM β-
mercaptoethanol, and 2 mM spermidine] for 20 min at 30°C.  The complex was 
filtered through a Millipore HA filter, and washed with binding buffer. Complex C 
was extracted off the filter disk by gently shaking in binding buffer containing 0.05% 
of Zwittergent 3-12 for 30min at 4°C.  Complex C extract was pre-incubated at 30°C 
for 5 min to activate ribosomes.  2mM puromycin was added to complex C in 100 μL 
of binding buffer P to begin the reaction. Time points were taken at 0, 2, 5, 10, 20, 30, 
60, 120 min by removing 100 μL aliquots and terminating the reactions by addition of 
100 μL of 1.0 N NaOH.  Reaction products were extracted with 0.5 ml of ethyl 
acetate, and radioactivity was determined by scintillation counting. Control values of 
reaction mixture without puromycin and of extracted complex C were obtained in 
each experiment.  The data were analyzed using Prism Graph Pad software and was 
fit to give the value of Kapp, the apparent rate constant of the entire reaction at a given 
concentration of puromycin using the equation Y=-Ae^(-kt)+C where Y is the 
normalized counts per minute (CPM), C is the final value of the normalized CPM, 
and t is the time in minutes.   
 
tRNA binding activity 
     Aminoacyl-tRNA binding to the A-site of the ribosome was carried out as 
previously described (Meskauskas et al., 2005).  Briefly, a reaction mixture of 12-25 




[80 mM Tris-HCl, pH 7.4, 11 mM magnesium acetate, 160 mM ammonium chloride, 
6 mM β-mercaptoethanol, and 2 mM spermidine] was preincubated with uncharged 
tRNA (4:1 tRNA/ribosomes) at 30°C for 15 min to occupy ribosomal P- and E-sites 
by uncharged tRNA.  The mixture is added to increasing amounts of [14C]Phe-tRNA 
(4 to 264 pmol) and incubated at 30°C for an additional 15 min to allow formation of 
[14C]Phe-tRNA–80S–poly (U) complexes. Aliquots were then applied to 
nitrocellulose membranes, washed, and the resulting radioactivity of the membrane 
was measured by scintillation counting. Background levels of radioactivity were 
determined using a blank sample and subtracted from the test samples.  The data were 
analyzed using Prism Graph Pad software and was fit to a nonlinear regression one 
site binding curve (Y=Bmax*X/(Kd + X)) where Y is normalized CPM values, and X 
is tRNA concentration in μM. 
 
     Acetyl-aminoacyl-tRNA binding to the P-site of the ribosome was carried out as 
similar to the A-site binding protocol with the following modifications.  Briefly, 
purified ribosomes in Buffer C were thawed on ice and treated with 1mM puromycin 
and 1mM GTP (adjust PMSF and DTE to 1mM) and incubated at 30°C for 30 min to 
remove aminoacyl-tRNAs.  A reaction mixture of 12-25 pmol treated ribosomes, 0.4 
mg/ml poly(U), and 50μl binding buffer P [80 mM Tris-HCl, pH 7.4, 11 mM 
magnesium acetate, 160 mM ammonium chloride, 6 mM β-mercaptoethanol, and 2 
mM spermidine] is added to increasing amounts of Ac-[14C]Phe-tRNA (4 to 264 




poly(U) complexes.  The protocol then proceeds as described above for aminoacyl-
tRNA binding reactions. 
 
Structure Probing on Ribosomes in vitro 
     Purified ribosomes in Buffer C were thawed on ice and treated with 1mM 
puromycin and 1mM GTP (adjust PMSF and DTE to 1mM) and incubated at 30°C 
for 30 min to remove aminoacyl-tRNAs.  Puromycin treated ribosomes were 
incubated with DMS (dimethyl sulfate), Kethoxal or CMCT (1-cyclohexyl-3-(2-
morpholinoethyl) carbodiimide metho-p-toluene) as previously described (Kiparisov 
et al., 2005). Treated rRNA was extracted and slow-cool annealed in annealing buffer 
(250mM TrisCl pH 8.3, 200mM KCl) to 32P-end-labeled primers (Table 4) which are 
used to investigate the ribosomal peptidyl-transferase center and A-loop.  Primer 
extension and RNA sequencing were both performed using AMV reverse 
transcriptase (Roche, Mannheim, Germany) at 42°C for 30 min.  Primer extensions 
were performed using 4μM dNTPs.  Reaction products were separated through a 10% 




     Previous studies have implicated rRNA modification defects with changes in 
growth rates, translation rates and ribosome integrity.  In order to more precisely 
determine the role of rRNA modifications in the translational fidelity of the ribosome, 




modify residues around the peptidyl-transferase center of the ribosome and performed 
assays on strains deficient in these modifications to monitor changes in translational 
fidelity.  These are single knockout strains of snoRNAs snR10, snR34, snR37, snR42, 
and snR46 which together pseudouridylate six rRNA residues in the PTC of the yeast 
ribosome, with snR34 modifying two of those residues.  Additionally, single and 
double knockout strain snr52 and a methylase deficient mutant of the essential yeast 
protein Spb1, which are responsible for methylation of mG2921 and mU2920, were 
analyzed (Figures 3.2 and 3.3).  Since Spb1p is an essential yeast protein, a methylase 
deficient mutant with a D to A substitution affecting the AdoMet-binding site was 
used (Bonnerot et al., 2003; Lapeyre and Purushothaman, 2004).  Mutant strains 
snr10Δ, spb1DA, and spb1DA/snr52Δ have slow growth phenotypes. 
 
rRNA modification mutants show sensitivity to translation inhibitors 
     Several protein translation inhibitors are known to specifically interact with the 
ribosome (Tenson and Mankin, 2006) and can therefore be used as probes for changes 
in ribosome function.  Paromomycin binds the decoding center of the A site (Vincens 
and Westhof, 2001) and stabilizes binding of near-cognate tRNAs (Ogle et al., 2001) 
can serve as a probe for A site-specific defects.  Anisomycin binds the A-site crevice 
that normally accepts the amino acid side-chains of A-site bound aminoacyl-tRNAs 
(Hansen et al., 2003b) interfering with the binding of 3’ end of the aa-tRNA 
(Grollman, 1967; Carrasco et al., 1973; Schindler, 1974) and can therefore be used as 
an A-site specific probe.  Sparsomycin binds on top of the CCA end of a P-site bound 












the 3’ end of the peptidyl-tRNA (Jayaraman and Goldberg, 1968; Herner et al., 1969; 
Moazed and Noller, 1991) and can be used as a P-site specific probe.  Previous 
studies reported that spb1DA mutants were sensitive to paromomycin, and that 
sparsomycin had no effect (Bonnerot et al., 2003).  The snr10Δ mutant was also 
shown to be sensitive to paromomycin (King et al., 2003).  In order to achieve a 
better understanding of the drug sensitivity profiles for all of the mutants, we 
performed standard 10-fold dilution spot assays on plates containing differing 
amounts for each of the translation inhibitors anisomycin and sparsomycin (Figure 
3.4).  The data show spb1DA/snr52Δ cells to be sensitive to anisomycin at a 
concentration of 20 µg/ml, with no effect on wild-type growth at this concentration.   
Wild-type strains show no change in growth on 20ug/ml sparsomycin, while mutants 
snr34Δ and snr46Δ were sensitive to the drug at this concentration. 
 
Virus propagation in rRNA modification mutants 
      The yeast killer virus system is composed of the dsRNA L-A helper virus and M1 
‘killer” satellite viruses.  The L-A virus genome consists of two overlapping ORFs, 
gag and pol, which encoded the structural protein and the RNA dependent RNA 
polymerase respectively.  The two ORFs are joined by a programmed –1 ribosomal 
frameshift signal where a –1 PRF event results in synthesis a gag-pol fusion protein.  
The M1 satellite virus genome encodes for a secreted toxin.  The pre-toxin provides 
the infected cell with immunity to the toxin, while secretion of the mature toxin 








the ratio of structural to enzymatic viral proteins produced for particle assembly 
thereby interfering with the ability of yeast to maintain the L-A helper and M1 
satellite viruses (Dinman and Wickner, 1992).  M1 propagation also depends on the 
level of free large subunits in yeast, such that mutants with altered amounts of free 
ribosomal LSU fail to maintain the M1 virus (Wickner, 1996).  The yeast killer virus 
model system can be utilized to identify defects in virus propagation as a possible 
result of altered translational fidelity, specifically programmed –1 ribosomal 
frameshifting.  Thus, the snoRNA mutants were screened to determine their ability to 
maintain the M1 killer virus as a phenotypic identifier of translational associated 
defects.  The L-A and M1 viruses were introduced into [rho0] wild-type and mutant 
cells and assayed for the killer phenotype (Figure 3.5a).  The data showed the wild-
type strains and several mutants were able to maintain the killer virus (K+).  However, 
the mutants snr37Δ and snr46Δ showed weak killer (Kw) phenotypes, snr10Δ rapidly 
lost the killer virus (K-), and severe viral maintenance defects were observed with the 
mutants spb1DA and spb1DA/snr52Δ.  Previously published data indicates altered 
ribosome profiles for mutants snr10∆ (King et al., 2003)and spb1DA/snr52Δ 
(Bonnerot et al., 2003) which included ribosomal LSU defects and could be a 
contributing factor to their virus propagation defects. 
 
     In order to rule out the possibility that a defect in the processing or secretion of the 
killer toxin (Wickner, 1996) is responsible for the observed killer phenotype and not 








mutant yeast cells and visualized (Figure 3.5b).  The analysis revealed that M1 dsRNA 
abundance correlated with the observed killer phenotypes; i.e. M1 dsRNA was  
observed the in the strains which showed the K+ phenotype and was absent or faint in 
strains that showed K- or Kw phenotypes respectively. 
rRNA modification mutants cause defects in translational fidelity 
     Defects in rRNA modification have been implicated in changes in translation rates 
and ribosome integrity (Gustafsson and Persson, 1998; King et al., 2003).  In order to 
more precisely determine the role of rRNA modifications in the translational fidelity 
of the ribosome, we have performed assays that monitor various aspects of 
translational fidelity, namely changes in programmed ribosomal frameshifting, aa-
tRNA selection, and nonsense suppression in vivo.  A bicistronic dual-luciferase 
reporter system, described in Figure 3.6, was developed to quantitatively monitor 
these changes in fidelity (Harger and Dinman, 2003).  The control reporter is a yeast 
expression vector containing Renilla and firefly luciferase genes, which yields active 
Renilla and firefly luciferase proteins.  Programmed –1 and +1 frameshifting test 
reporters are constructed by inserting a frameshift signal, L-A or Ty1 respectively, 
between the Renilla and firefly genes such that firefly luciferase is only produced in 
the event of a frameshift.  Renilla luciferase serves as an internal control thereby 
eliminating effects due to differences in mRNA abundance, mRNA stability or 
translation rates between the test and control reporters.  Nonsense suppression test 
reporters contain a stop codon (UAA, UAG, or UGA) six nucleotides into the firefly 
luciferase gene; therefore, firefly luciferase is only produced when nonsense 








firefly catalytic residue R218 from the wild-type AGA codon to either the near-
cognate AGC codon or non-cognate TCT codon the result of which is that active 
firefly luciferase is only synthesized when the incorrect tRNAArg is selected.  
Recoding efficiencies were measured for each mutant as described in the methods.  
The data are represented as fold wild-type values and summarized in Table 1.   
 
     The spb1DA/snr52∆ double mutant showed the largest increase in –1 PRF 
efficiency (1.5 fold of wild-type) (Figure 3.7).  This result is in agreement with the 
viral propagation data as this mutant was unable to propagate the M1 killer virus.  
Subtle increases in –1 PRF were observed in a few mutant strains (1.2 fold or lower).  
Only small (1.2 fold or lower) increases in +1 PRF were observed in any of the 
mutants (Figure 3.7).   
      
     Values for near and non-cognate aa-tRNA selection events are reported in Figure 
3.8.  The snr10Δ mutant strain displayed small increases in both near and non cognate 
aa-tRNA selection events (both 1.3 fold).  The mutant snr46Δ shows a small increase 
in only non-cognate aa-tRNA selection at 1.3 fold of wild type.  The double mutant 
spb1DA/snr52Δ shows a significant 1.9 fold increase in near cognate aa-tRNA 
selection events and a very slight increase in non-cognate aa-tRNA selection at 1.2 
fold which is higher value than that of either of the single mutants.  The spb1DA 
single mutant actually exhibits a slight (0.8 fold) decrease in non-cognate aa-tRNA 








selection events.  The snr52Δ single mutant shows no change in non-cognate aa-
tRNA selection events, but does display a 1.4 fold increase in near-cognate values. 
   
     Nonsense suppression efficiencies were measured for each stop codon (UAA, 
UAG, and UGA) and reported in Figure 3.9.  With the exception of snr42Δ, similar 
trends for changes in nonsense suppression are observed for all three stop codons in 
each mutant strain.  Decreases in nonsense suppression ranging from 0.3 to 0.8 fold 
of wild-type were observed in mutant strains snr37Δ, snr10Δ and the double mutant 
spb1DA/snr52Δ.  A significant increase in nonsense suppression was displayed in the 
snr46Δ mutant strain with values of 1.4, 2.0 and 1.3 fold of wild-type for stop codons 
UAA, UAG and UGA respectively. 
 
Changes in aminoacyl-tRNA binding and peptidyl transfer rates 
     Defects in translational fidelity could possibly be due to changes in tRNA binding 
to the ribosome and peptidyl-transfer rates.  Two phenotypically interesting mutants 
were chosen and biochemically characterized.  The mutant strains chosen were 
snr46Δ and spb1DA/snr52Δ.  The mutant snr46Δ showed sparsomycin sensitivity, the 
Kw phenotype, no significant change in +1 and –1 PRF, and exhibited increases in 
non-cognate aa-tRNA selection events and nonsense suppression  The double mutant 
spb1DA/snr52Δ was anisomycin sensitive, could not propagate the M1 virus, showed 
an increase in –1 PRF, an increase in near-cognate aa-tRNA selection events, and 








types and mutant strains and the affinities for aa- and peptidyl-tRNA as well as 
peptidyl transfer rates were determined as described in the methods.  The binding 
constants determined for aa-tRNA affinity to mutant and wild-type ribosomal A-site 
indicated increased binding to the A-site for both mutants (Figure 3.10).  The wild-
type isogenic to the mutant snr46Δ Kdapp was 1.8 µM-1 ±0.4 while the mutant Kdapp 
was determined to be 0.3 µM-1 ±0.05.  Similarly, wild-type SPB1 SNR52 was shown 
to have a Kdapp of 0.6µM-1 ±0.2 while the mutant strain spb1DA/snr52Δ showed a 
Kdapp of 0.3 µM-1 ±0.1.  Different wild-type binding constants are observed because 
the two wild-type stains are not isogenic.  Affinities of tRNA for the ribosomal P-site 
were measured as described in methods using [14C]-Ac-Phe-tRNA and the isogenic 
wild-type and mutant ribosomes (Figure 3.11).  There was no change in Kdapp for P-
site binding of either mutant when compared to their isogenic wild-type strain.  
Peptidyl-transfer rates were measured using the puromycin reaction as described in 
the methods.  Both mutant strains displayed increases in peptidyl-transfer rates when 
compared to isogenic wild-type values (Figure 3.12).  The Kapp of the mutant snr46Δ 
was 0.06 min-1 ±0.003 while its isogenic wild-type showed a Kapp value of 0.04 min-1 
±0.003.  Wild-type SPB1 SNR52 was shown to have a Kapp of 0.02 min-1 ±0.004 
while the mutant strain spb1DA/snr52Δ showed a Kapp of 0.04 min-1 ±0.007.   
 
Structure changes observed in the PTC of a modification deficient ribosome 
    It has been speculated that the post-transcriptional nucleotide modification like that 
demonstrated in rRNA could serve to increase the stability of the local RNA structure 

























Table 1:   
Summary of rRNA modification mutant phenotypes 





in mind, in vitro structural probing was performed on the wild-type and mutant 
ribosomes biochemically characterized in the previous section.  Mutants snr46Δ and 
spb1DA/snr52Δ and isogenic wild-type puromycin treated ribosomes were incubated 
with the chemically modifying agents CMCT, kethoxal and DMS in vitro.  The 
rRNAs were extracted and primer extension analyses performed using primers 
sufficient to transverse the entire PTC i.e. helices 89-93.  Figure 3.13 shows a 
representative autoradiogram for the wild-type and mutant spb1DA/snr52Δ strains 
with each primer 25-6 and 25-10.  Observed differences between wild-type and 
mutant protection patterns and their nucleotide locations are indicated.  Residues 
C2843 and C2851 in helix 93 were deprotected in the presence of DMS treatment.  
The A-loop residue U2923 showed increased protection from CMCT treatment.  
There were no significant differences between protection patterns observed for 




       Although decoding takes place in the small ribosomal subunit, it is not surprising 
that the large subunit would play a part in determining translational fidelity.  The 
large subunit interacts with all but the anti-codon stems of both the A- and P- site 
tRNAs, binds elongation factors including the EF-Tu:GTP:tRNA13 ternary complex 
and EF-G:GTP14, and is the site of release factor binding.  Previous studies have 
shown that mutations in rRNA residues of helix 89 in the peptidyl transferase center 
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of E. coli ribosomes result in defects in stop codon recognition and reading frame 
maintenance (O'Connor and Dahlberg, 1995).  Interestingly, residues in helix 89 
along with other residues within the peptidyl transferase center are post-
transcriptionally modified, although the functional contributions of this residue are 
unknown.  The snoRNAs characterized in the current are snR10, snR34, snR37, 
snR42, snR46, snR52 and the essential yeast protein Spb1p which modify residues 
Ψ2922, Ψ2825/Ψ2879, Ψ2943, Ψ2864, Um2920 and Gm2921 respectively.  The modified 
residues are located on helices 89-93 of the PTC of the yeast ribosome (Figures 3.2 
and 3.3).  Modification of residue Ψ2825 is guided by snR34 in yeast and is conserved 
through evolution.  However, deletion of snR34 or RluE, the gene responsible for the 
homologous modification in E. coli, conferred no obvious disadvantage (Samarsky et 
al., 1995; Del Campo et al., 2001; King et al., 2003).  Residues Um2920 and Gm2921 
modified by snR52 and the protein Spb1p respectively are also conserved throughout 
evolution. Residue Gm2921 has been shown to interact with the 3’ end C75 of the A-
site tRNA (Mueller et al., 2000).  Strains lacking each of these eight PTC 
modifications, and one strain lacking two were investigated to determine the 
contributions that each of these modifications made to translational fidelity. 
 
     Biochemical characterization of the spb1DA/snr52∆ double mutant revealed an 
increase in peptidyl transfer rates for the mutant ribosome as determined by the 
puromycin reaction assay.  Since peptidyl transfer is an extremely fast reaction, 
occurring almost instantaneously (Katunin et al., 2002), it is interesting that mutant 




data, it is necessary to analyze them in the context of the assay.  Puromycin is an A-
site tRNA analog that mimics its aminoacylated 3’CCA end (de Groot et al., 1970; 
Hansen et al., 2003a).  The puromycin reaction assay involves the diffusion of 
puromycin into the A-site of ribosomes pre-loaded with peptidyl-tRNA, peptidyl 
transfer takes place and the resulting puromycin bound tRNAs are measured. 
Therefore, any increase in peptidyl transfer rates could result from an increase in the 
rate at which puromycin diffuses into the A-site.  This could suggest that these mutant 
ribosomes have A-sites that are more accessible.  Structure probing analyses of 
spb1DA/snr52∆ mutant ribosomes demonstrated changes in the protection patterns 
that are consistent with a more open A-site conformation (Figure 3.13).  Two 
residues, C2843 and C2851, displayed decreased protection from DMS treatment, and 
one residue, U2923, showed increased protection from CMCT.  Residue C2851 is 
located on helix 89 and makes direct contacts with the A-site tRNA (Figure 3.14).  
The fact that the residue is deprotected suggests that contacts with the A-site tRNA 
are abolished possibly resulting in a more open conformation around the A-site 
tRNA.  Residue U2923 provides further insight into the A-site changes observed for 
this mutant.  This residue is located on the A-loop and is adjacent to the gate residue 
C2924, one of the nucleotides which form the first gate that the 3’ of the aa-tRNA has 
to pass through as it accommodates into the PTC (Figure 3.14).  This residue is also 
two and three nucleotides away from residues Gm2921 and Um2920, respectively, 
which are lacking their modifications in this mutant.  It may be that the absence of 
these methylations causes a shift in the local conformation causing U2923 to move 








shift as well, most likely away from its partner residue, U2860, involved in creating 
the first gate.  This would open up the first gate producing a more accessible 
conformation with less steric hindrance to puromycin diffusion which would result in 
the observed increase in peptidyl transfer rates. 
 
     All other biochemical and genetic phenotypes observed for this mutant are in 
agreement with this model.  Further biochemical characterization of spb1DA/snr52∆ 
revealed increased rates of A-site tRNA binding.   The open conformation of the A-
site in mutant ribosomes would allow for easier accommodation of the aa-tRNA 
thereby resulting in this observed increase in affinity for aa-tRNA.    It would also 
follow that opening up the A-site and disabling the accommodation gate would 
produce a less discriminate A-site.  This is consistent with the observed increase in 
near cognate aa-tRNA selection events (1.9 fold of wild-type) for the spb1DA/snr52∆ 
mutant strain.   
 
     The mutant also promoted increased rates of -1 PRF (1.5 fold over wild-type) and 
demonstrated anisomycin sensitivity.  These two phenotypes are usually associated 
with decreased A-site binding, while increased A-site binding usually correlates with 
anisomycin resistance (Meskauskas et al., 2003; Meskauskas et al., 2005).  Normally, 
defects in the ribosome that decrease its affinity for A-site tRNA also lead to 
increases in -1 PRF through an increased pause time during accommodation allowing 
more time for slippage, and since anisomycin can compete with A-site tRNA binding 




additional problems with accommodation resulting in reduced viability in the 
presence of anisomycin.  Here, we see ribosomes with an increased affinity for A-site 
tRNA but are sensitive to anisomycin.  However, these data could result from a more 
open, less discriminate ribosomal A-site.  A less stringent A-site may promote the 
binding of, or increase the diffusion rates for, small molecules like anisomycin.  This 
could interfere with peptidyl transfer causing the decreased growth in the presence of 
anisomycin observed for the mutant strain.  It may also be that a less discriminate A-
site with a more open conformation could better facilitate tRNA slippage thereby 
increasing -1 PRF rates.  Additionally, the deprotection of residue C2851 may 
indicate suboptimal placement of the A-site tRNA which could also facilitate slippage 
thereby increasing -1 PRF rates.  The inability of the spb1DA/snr52∆ mutant strain to 
propagate the killer virus is consistent with increased -1 PRF efficiencies.  However, 
previous studies have also indicated that this mutant displayed altered ribosome 
profiles (Bonnerot et al., 2003) which could also contribute to its complete inability to 
maintain the killer virus independent of changes in -1 PRF (Ohtake and Wickner, 
1995a).  Finally, that +1 PRF, which only involves peptidyl-tRNA slippage, was not 
affected is consistent with the lack of effects on P-site tRNA binding and with the 
absence of structural changes in the area surrounding the peptidyl-tRNA.   
 
     All mutant strains were also tested for changes in nonsense suppression for all 
three stop codons, and phenotypic changes were observed for several mutants 
including spb1DA/snr52∆.  Class 1 release factors span the decoding center to the 




local conformation of the large subunit in the PTC region of the yeast ribosome 
would have affects on translation termination.  Cryo-EM structures of a class 1 
release factor bound to the E. coli ribosome indicate that regions of the protein make 
contacts with portions of the large subunit including the GTPase associated center, 
and helices 89, 92 and 93 of the PTC (Figure 3.15) (Klaholz et al., 2003; Petry et al., 
2005).  Mutant strain spb1DA/snr52∆ exhibited a decrease in nonsense suppression 
for all three stop codons when compared to wild-type values indicating an increase in 
the fidelity of stop codon recognition.  Since spb1DA/snr52∆ demonstrated an 
increase in near cognate aa-tRNA selection events, it is surprising that the fidelity of 
stop codon recognition was increased.  It may be that the mechanisms allowing for 
less stringent aa-tRNA selection extends to the binding and recognition of the release 
factor thereby increasing stop codon recognition.  It may also be that changes in the 
PTC of these mutants facilitate the peptidyl-tRNA hydrolysis reaction.  Crystal 
structure analysis of the ribosome in complex with release factors 1 and 2 show the 
conserved RF1 GGQ motif in close proximity to the A loop of the peptidyl 
transferase center (Figure 13.6).  Since the mutant strain spb1DA/snr52∆ lacks the 
methylation of two residues found on the A-loop, it is conceivable that these mutant 
ribosomes could alter release factor binding or activity either through direct 
interactions or by inducing local conformational changes.  Structure probing analyses 
of themutant strain spb1DA/snr52∆ did demonstrate an increased protection for 
residue U2923 which is also located on the A-loop indicating local conformational 

















     These data taken together suggest that the mutant ribosomes harboring 
methylation deficient residues U2920 and G2921 have a less discriminate A-site with 
a more open conformation.   It would appear that residues Um2920 and Gm2921  
function, at least in part, to facilitate entry of the proper aa-tRNA into the A-site by 
correctly positioning helix 89 and the gate residue C2924.   
 
     Structure probing of spb1DA/snr52∆ mutant ribosomes also revealed the 
deprotection of residue C2843 which makes direct contact with the GTPase 
associated center (GAC) of the ribosome.  An alternative, but not mutually exclusive, 
explanation to the one proposed above could be that changes in the conformation of 
this functional center of the ribosome could also cause the changes in both nonsense 
suppression and the decreased discrimination in aa-tRNA selection.  The GAC is a 
flexible region of the ribosome and its conformation changes with its functional state 
(Valle et al., 2003).  It has been proposed that the different orientations of the GAC 
provide factor binding discrimination between EF-Tu:GTP and EF-G:GTP  (Sergiev 
et al., 2005a).  Interestingly, mutational studies of LSU rRNA designed to mimic the 
different GAC conformations demonstrates changes in chemical protection patters for 
helix 89 when the GAC position is altered (Sergiev et al., 2005b)  It may be that the 
structural changes observed for the spb1DA/snr52∆ mutant ribosomes on helix 89 
where it contacts the GAC indicates changes in the local conformation affecting the 
GAC.  This could alter interactions with EF-Tu causing changes in initial tRNA 
binding and subsequent GTP hydrolysis which may explain the decrease in aa-tRNA 




in the GAC that would interfere with EF-G binding and translocation could increase 
the pause time during -1PRF thereby increasing the chance for slippage resulting in 
the observed increase in -1PRF efficiencies.  It has also been shown that mutations in 
the GAC in E. coli ribosomes can affect nonsense suppression by causing an increase 
in stop codon readthrough (Arkov et al., 1998).  Therefore, it is not unreasonable to 
speculate that changes in the local conformation of the GAC and the PTC could cause 
the observed decrease in stop codon readthrough seen for the spb1DA/snr52∆  mutant 
strain.  Further structure probing analyses of the GAC and surrounding areas would 
be required to investigate this model. 
 
      tRNA binding experiments performed with snr46∆ mutant ribosomes revealed an 
increase in A-site tRNA binding when compared to wild-type ribosomes, but no 
effect on P-site binding.  This result was somewhat unexpected because the mutant 
strain also exhibited sparsomycin sensitivity which would suggest a P-site specific 
defect.  This may be explained by the nature of sparsomycin.  Although sparsomycin 
does not interfere with A-site substrate binding (Goldberg and Mitsugi, 1966; Monro 
et al., 1969), it does compete with A-site binding antibiotics for binding to the 
bacterial ribosome (Barbacid and Vazquez, 1974; Lazaro et al., 1991). Additionally, 
mutating residues or eliminating a modification of a residue in the PTC not in the P-
site of Halobacterium results in sparsomycin resistance (Lazaro et al., 1996; Tan et 
al., 1996).  Presumably, this is because sparsomycin stacks with the flexible A2606 
(E. coli numbering; yeast A2970) upon binding to unoccupied ribosomes causing 




the PTC of the mutant snr46∆ is altered in such a way as to foster increased 
sensitivity to sparsomycin.  Increased rates of A-site tRNA binding for snr46∆ can be 
consistent with slightly increase in non-cognate aa-tRNA selection events (1.3 fold 
over wild-type) in that increased rates of the forward reaction involved in initial 
selection, GTP hydrolysis, could both increase rates of A-site tRNA binding and more 
easily allow for the incorporation of non-cognate tRNAs.  Further biochemical 
analyses revealed that the mutant strain snr46Δ also promoted increased rates of 
peptidyl transfer.  However, structure probing of helices 89-93 of snr46Δ mutant 
ribosomes with CMCT, DMS and kethoxal failed to reveal any major changes in 
structure.  It may be, that since accommodation is the rate limiting step for peptidyl 
transfer, mutant ribosomes with increased rates of A-site tRNA binding would lead to 
an increased rate of peptidyl transfer when compared to wild-type ribosomes.  Since 
these mutant ribosomes also exhibit increased accessibility to sparsomycin, this may 
reflect increased accessibility of the ribosome to puromycin as well.  It is also 
possible that structural changes are present in snr46Δ mutant ribosomes but are too 
subtle to be detected by the techniques used.  
 
     Mutant strain snr46∆ displayed an increase in nonsense suppression indicating a 
decrease in the fidelity of stop codon recognition.  This mutant also showed increase 
in non-cognate aa-tRNA selection.  It would appear that defects in translational 
fidelity of this mutant extend into inefficient stop codon recognition as well as a less 
stringent aa-tRNA initial selection step.  Structure probing of the helices in the PTC 




snR46 pseudouridylates a residue at the base of helix 89, and mutations made in helix 
89 have previously been shown to cause increased rates of stop codon readthrough 
(O'Connor and Dahlberg, 1995).  Helix 89 also comes in contact with the GTPase 
associated center of the ribosome which has also been implicated in changes in stop 
codon readthrough (Arkov et al., 2002).  Therefore, it is conceivable that changes 
made in this region could produce nonsense suppression phenotypes.  It may also be 
that structural changes are present in areas of snr46Δ mutant ribosomes that were not 
the focus of the chemical probing experiments. 
 
     These data, taken together, show that rRNA nucleotide modifications produce 
small but distinct changes in ribosome structure and function contributing to overall 
translational fidelity.  The double mutant spb1DA/snr52∆ displayed the most severe 
phenotypic defects.  This is most likely due to dramatic changes in local rRNA 
structure resulting from the loss of the methyl groups on two adjacent rRNA residues 
in the A-loop.  Significant changes in translational fidelity were observed in mutant 
strain snr46Δ, although no changes in structure were perceived for this mutant.  It 
may be that this and other mutants do result in changes in rRNA structure, but that 
they were too subtle to be detected by the methods employed.  However, their effects 
were magnified by the biological process, such that they resulted in the observed 
phenotypes.  Our conclusion is that rRNA base modification serves to fine-tune 
ribosome structure by facilitating structural conformations that promote optimal 





Chapter 4: Conclusions and Future Directions 
 
     Vast amounts of cellular resources are dedicated to production of ribosomes.  It is 
a very complex and highly coordinated process.  Central to this process is the 
manufacture, modification and assembly of ribosomal RNA.  Analyses in this study 
strive towards achieving a better understanding of the role modifying enzymes play in 
rRNA production and the resulting integrity of the final product. 
 
     The RPD3 gene encodes a histone deacetylase that is involved in silencing of the 
HM mating loci, telomeres and rDNA in yeast.   A mutant allele of RPD3, mof6-1 
demonstrated defects in rRNA processing resulting in changes in translational 
fidelity.   Mutant phenotypes included sensitivity to the translational inhibitors 
anisomycin and paromomycin, increased rates of programmed -1 ribosomal 
frameshifting, decreased growth rates which was most severe in lag phase growth, 
and decreased protein synthesis rates.   Biochemical characterization revealed 
decreased rates of A-site aa-tRNA binding and peptidyl transfer.  Mutant phenotypes 
were dependent on histone deacetylase activity.  These mutant phenotypes may be a 
result of altered timing of rRNA processing events.  Alternatively, mutating RPD3 
may interfere with the transcription of rRNA processing pathway components 
including snoRNAs.  It is also interesting to speculate that there may be a novel 
function for RPD3 perhaps involving modification of ribosomal proteins or other 





     An integral part of rRNA processing during ribosome biogenesis is the 
modification of rRNA residues.  In eukaryotes, rRNA modifications are guided by 
box H/ACA and C/D snoRNAs.  These modifications cluster in conserved regions of 
functional importance within the ribosomes.  They are present in ribosomes of all 
kingdoms studied to date and their numbers increase with evolutionary complexity.  
However, individual modifications are usually dispensable for cell viability.  Despite 
extensive mapping and study of these modified residues, their precise function is 
largely unknown.  Here we have analyzed several mutants deficient in rRNA 
modifications of the peptidyl transferase center of the yeast ribosome for changes in 
translational fidelity.  The data reveal a vital role for at least two rRNA modifications 
in ensuring the accommodation of the correct aa-tRNA into the A-site of the 
ribosome, and another modification that appears to be involved in the fidelity of 
translation termination. 
 
     The mutant strain spb1DA/snr52Δ was deficient in the methylation of A-loop 
residues Um2929 and G2921.  This mutant demonstrated increased sensitivity to the 
translation inhibitor anisomycin and changes in translational fidelity including 
increased in rates of programmed -1 ribosomal frameshifting, increased near cognate 
aa-tRNA selection events, and a decrease in rates of nonsense suppression.  
Biochemical characterization of the mutant ribosomes demonstrated an increase in 
rates of peptidyl transfer and increased affinity of the ribosome for A-site tRNA.  
Structural probing revealed deprotection of two residues in helix 89 C2843 and 




respectively.  Taken together, these data suggest that the absence of these 
modifications produces a more available, less discriminate conformation of the 
ribosomal A-site.  This was supported by further evidence provided by structure 
probing experiments.  Another residue, U2923, demonstrated increased protection in 
mutant ribosomes.  This residue is adjacent to one of three ‘gate’ residues in the A-
loop of the PTC.  These gate residues are responsible for monitoring the 
accommodation of the 3’ end of the aa-tRNA into the A-site of the ribosome.  The 
conformation change in a residue U2923, along with all the other data, suggests that 
the gate residue is no longer spatially oriented to correctly monitor the entrance of the 
aa-tRNA into the A-site.  The resulting open conformation leads to a more 
promiscuous A-site.  These data show that individual rRNA modifications may be 
dispensable for cell viability, but they provide important functional contributions to 
the accuracy of translation elongation and termination. 
 
     There are other functionally important areas of the ribosome that contain a high 
density of rRNA modifications.  For example, the loop of helix 69 has at least three 
modified residues and it is known to make intersubunit contacts, and interacts with A- 
and P-site tRNAs (Yusupov et al., 2001).  Functional studies in E. coli revealed 
defects in translational fidelity for mutants of helix 69 (Hirabayashi et al., 2006).  
Extensive genetic, biochemical and structural analysis of this helix would likely 






     Another interesting facet of rRNA modification is its possible role in human 
disease.  X-linked dyskeratosis congenital (X-linked DC) causes skin and bone 
marrow failure in humans.  It is caused by point mutations in the gene encoding the 
nucleolar protein dyskerin.  Dyskerin is present in the telomerase complex and in 
ribonucleoparticles that pseudouridylate rRNA residues.  Mutations in dyskerin are 
associated with severe telomere dysfunction and defects in pre-rRNA processing and 
the involved machinery (Mochizuki et al., 2004).  Interestingly, cells with mutant 
dyskerin activity also demonstrate a defect in translation of messenger RNAs 
containing IRES elements (Yoon et al., 2006).   It would be interesting to explore the 
possible relationship between rRNA modification and regulation if IRES dependent 





Appendix A: Yeast Strains 
 
 
Strain  Description 
5X47 MATa/MATα his1/+ trp1/+ ura3/+ K–; Standard diploid killer tester 
JD758 MATa kar1-1 arg1 [L-AHN M1] 
JD759 MATα kar1-1 arg1 [L-A HN M1] 
JD469-2D MAT_ leu2-1::pJD85 ura3 his4 mof6-1 
JD932D MATa ade2-1 trp1-1 ura3-1 leu2-3,112 his3-11,15 can1-100 [L-AHN 
M1] 
LNY95 MATa ura3-SK1 leu2-hisG trp1-hisG lys2-SK1 ho::LYS2 ade3-210S 
JD972A MATa ura3-SK1 leu2-hisG trp1-hisG lys2-SK1 ho::LYS2 ade3-
210SPEX6::URA3 
 
YMH171 MATα ura3-52 leu2-3,112 his3 trp1Δ 
YMH265 MATα ura3-52 leu2-3,112 his3 trp1Δsin3::LEU2 
YMH270 MATα ura3-52 leu2-3,112 his3 trp1Δ rpd3::LEU2 
YMH277 MATα ura3-52 leu2-3,112 his3 trp1Δ sap30::LEU2 
AJ82 MATα trp1 leu2 ura3 his4 UME6 
AJ82 11-2 MATα trp1 leu2 ura3 his4 ume6-11-2 
AJ82 66-2 MATα trp1 leu2 ura3 his4 ume6-66-1 
AJ82 77-2 MATα trp1 leu2 ura3 his4 ume6-72-2 
1105 MATα  ura3-52  leu2-3,112  his3  trp1∆  
1106 MATα  ura3-52  leu2-3,112  his3  trp1∆  sin3::LEU2 
1107 MATα  ura3-52  leu2-3,112  his3  trp1∆   rpd3::LEU2 
1108 MATα  ura3-52  leu2-3,112  his3  trp1∆   sap30::LEU2 
1187 
 
MATα  ade2-101  trp1-∆101  ura3-52  leu2-3, 112  his3∆200 
1188 
 


















MATa  ade2-101  trp1-∆101  ura3-52  leu2-3, 112  his3∆200  snr10::LEU2 
1191 
 
MATα  ade2-101  trp1-∆101  ura3-52  leu2-3, 112  his3∆200  snr34::LEU2 
1192 MATα  ade2-101  trp1-∆101  ura3-52  leu2-3, 112  his3∆200  snr46::HIS3 
 
1316 MATa ade2-1 his3-11 leu2-3 112 trpΔ ura3-1 can1-100 spb1Δ::TRP1 pSEY18-
SPB1-OR19(CEN, URA3,Spb1) 
1317 MATa ade2-1 his3-11 leu2-3 112 trpΔ ura3-1 can1-100 spb1Δ::TRP1 p(CEN, 
LEU2,HASpb1DA) 
 
1318 MATα ade2-1 his3-11 leu2-3 112 trpΔ ura3-1 can1-100 snR52Δ::TRP1 
 
1319 MATa ade2-1 his3-11 leu2-3 112 trpΔ ura3-1 can1-100 spb1Δ::TRP1 





Appendix B: Plasmid List 
 
Strain  Description 
pJD375 0-frame control dual luciferase reporter test (DLR).  Described 
previously (Harger and Dinman, 2003) and Figure 3.6.  Harbors a URA3 
selectable marker. 
 
pJD376 -1 PRF test DLR.  Described previously (Harger and Dinman, 2003) and 
Figure 3.6.  Harbors a URA3 selectable marker. 
 
pJD 377 +1 PRF test DLR.  Described previously (Harger and Dinman, 2003) and 
Figure 3.6.  Harbors a URA3 selectable marker. 
 
pJD 419 0-frame control dual luciferase reporter test (DLR).  DLR cassette 
identical to that in pJD375.  Harbors a LEU2 selectable marker. 
 
pJD 420 -1 PRF test DLR.  DLR cassette identical to that in pJD376.  Harbors a 
LEU2 selectable marker. 
 
pJD 421 +1 PRF test DLR.  DLR cassette identical to that in pJD377.  Harbors a 
LEU2 selectable marker. 
 
pJD431 Nonsense suppression test DLR.  Contain the UAA premature 
termination codon.  Described in Figure 3.6.  Harbors a URA3 selectable 
marker. 
 
pJD 432 Nonsense suppression test DLR.  Contain the UAG premature 
termination codon.  Described in Figure 3.6.  Harbors a URA3 selectable 
marker. 
 
pJD433 Nonsense suppression test DLR.  Contain the UGA premature 
termination codon.  Described in Figure 3.6.  Harbors a URA3 selectable 
marker. 
 
pJD633 0-frame control dual luciferase reporter test (DLR).  DLR cassette 
identical to that in pJD375.  Harbors a TRP1 selectable marker. 
 
pJD634 -1 PRF test DLR.  DLR cassette identical to that in pJD376.  Harbors a 
TRP1 selectable marker. 
 
pJD635 +1 PRF test DLR.  DLR cassette identical to that in pJD377.  Harbors a 
TRP1 selectable marker. 
 
pJD642 Non-cognate tRNA misincorporation test DLR.  Described in Figure 3.6.  
Harbors a URA3 selectable marker. 
 






Table 3: Plasmid List Continued 
Strain  Description 
pJD643 Near-cognate tRNA misincorporation test DLR.  Described in Figure 3.6.  
Harbors a URA3 selectable marker. 
 
pJD676 Non-cognate tRNA misincorporation test DLR.  DLR cassette identical 
to that of pJD643.  Harbors a TRP1 selectable marker. 
 
pJD677 Near-cognate tRNA misincorporation test DLR.  DLR cassette identical 
to that of pJD644.  Harbors a TRP1 selectable marker. 
 
pJD699 Non-cognate tRNA misincorporation test DLR.  Described in Figure 3.6.  
Harbors a URA3 selectable marker. 
 
pJD700 Near-cognate tRNA misincorporation test DLR.  DLR cassette identical 
to that of pJD644.  Harbors a TRP1 selectable marker. 
 
pJD702 Non-cognate tRNA misincorporation test DLR.  Described in Figure 3.6.  
Harbors a URA3 selectable marker. 
 
pJD703 Nonsense suppression test DLR.  Contain the UAG premature 
termination codon.  DLR cassette identical to that of pJD43.  Harbors a 
LEU2 selectable marker. 
 
pJD704 Nonsense suppression test DLR.  Contain the UGA premature 
termination codon.  DLR cassette identical to that of pJD433.  Harbors a  
LEU2 selectable marker. 
 
p0 lacZ containing 0 frame control reporter for measuring  -1PRF using β-
galactosidase activity 
 
















































PCR primer 4 
(forward SalI) CCCCGTCGACTCAAAATTAGCTCTCACCGC 
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